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Executive Summary: National Biosurveillance 
Strategy for Human Health 
The United States faces many potential threats to human health, including natural disease 
outbreaks, environmental exposures, and acts of terrorism. In today’s modern world of high-
density population centers and global mass transit such threats and hazards can significantly 
impact human health. These potential threats speak to the need for an integrated all-hazards 
approach to health security by all sectors of society. At the same time, the broader and more 
sophisticated use of information technology, new information sources, and analytic techniques 
holds the potential to accelerate recognition of health threats and improve the accuracy of 
assessments. With greater availability and real-time delivery of health information it may be 
possible to maintain a comprehensive picture of the nation’s health and detect aberrations in 
illness patterns faster and more accurately.
These new opportunities and increasing threats demand a national vision for biosurveillance that 
builds on existing capabilities and relationships while investing in innovative and science-driven 
tools and methods. Effective biosurveillance embraces a complementary “system of systems” 
that leverages the data collection and analyses performed at the local level while incorporating 
broader national perspectives. 
Biosurveillance in the context of human health is a new term for the science and practice of 
managing health-related data and information for early warning of threats and hazards, early 
detection of events, and rapid characterization of the event so that effective actions can be taken 
to mitigate adverse health effects.  It represents a new health information paradigm that seeks to 
integrate and efficiently manage health-related data and information across a range of
information systems toward timely and accurate population health situation awareness. 
The scope and function of biosurveillance includes the following:   
	 All hazards: including biological, chemical, radiological, nuclear and explosives
	 Defined by urgency and potential for multi-jurisdictional interest  
	 Urgent notifiable conditions and non-specific and novel health events  
	 Ad hoc data gathering, analysis, and application of information  
	 Functions: Case Detection, Event Detection, Signal Validation, Event Characterization, 

Notification and Communication and, Quality Control and Improvement 

	 Supports rapid and efficient discharge of responsibilities for the International Health 

Regulations [IHR (2005)] 

The National Biosurveillance Strategy for Human Health (hereafter The Strategy) articulates a 
vision for enhanced biosurveillance and is intended to guide national interests to: 
	 Implement a national enterprise of complementary biosurveillance systems that provides 

relevant, accurate and timely information for government, healthcare, business, and 

personal decision-making for planning and responding to population health emergencies; 
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	 Coordinate health-related information sharing, according to defined data sharing policies, 

both vertically and horizontally across all levels of government, jurisdictions, and health-

related disciplines to improve the effectiveness of disease monitoring and response; 

	 Prioritize improvements to existing biosurveillance efforts and infrastructures; 
	 Ensure biosurveillance data is available for local use, where it is best understood and 

managed; 

	 Develop new relationships while continuing to leverage and maintain existing ties between 
local public health professionals and data providers;  
	 Engage a diverse consortium of governmental, non-governmental, academic, and business 
sector stakeholders in the complex and distributed national enterprise of biosurveillance for 
human health;   
	 Optimize resources to support biosurveillance and broader public health needs; and  
	 Address all hazards while assuring flexibility and specificity of biosurveillance methods as 
required to monitor and investigate cases at the local level.  
The Strategy provides the foundation for a long-term effort to improve a nationwide capability to 
manage health-related data and information. It is grounded in U.S. laws and Presidential 
Directives, including Homeland Security Presidential Directive-21 (HSPD-21), “Public Health 
and Medical Preparedness”, which names biosurveillance as one of four critical priorities for 
improving public health preparedness. HSPD-21 also mandates the development of a nationwide 
integrated biosurveillance capability, as well as the establishment of a federal advisory 
committee. As a result, the National Biosurveillance Advisory Subcommittee (NBAS), which 
includes private sector representatives, and state and local government public health authorities, 
was established to help carry out these mandates. This subcommittee to the Advisory Committee 
to the Director (ACD), Centers for Disease Control and Prevention (CDC), Department of Health 
and Human Services (HHS), produced their first report which includes recommendations to 
strengthen the nation’s biosurveillance capability and provides counsel to the federal government 
regarding a broad range of issues affecting a nationwide biosurveillance strategy for human 
health. That report has helped shape The Strategy document. 
The continued development and implementation of The Strategy is informed by the following 
principles that define how stakeholders will plan and work together: 
	 Building on current capabilities and relationships 
	 Establishing data and technical standards and promoting interoperability of platforms
	 Respecting multi-organizational and multi-disciplinary perspectives
	 Building Federal, State and Local trust 
	 Assuring value for stakeholders 
	 Ensuring protection of rights and authorities 
The Strategy is a product of collaboration across several multi-disciplinary working groups, and 
engagements with additional biosurveillance stakeholders. The Strategy will continue to evolve 
through stakeholder input and will be periodically updated as requirements change and 
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opportunities for improvement are recognized. The network of stakeholders includes Federal 
Agencies and State, Local, Territorial and Tribal Governments, the Healthcare Industry and 
International Partners. While having broader missions, the professional communities protecting
Animal, Plant and Environmental Health also have direct impact on human health security and 
are stakeholders as well. Private Sector, Academia, and Community-based Organizations are also 
vital partners in creating the biosurveillance capability necessary to prevent and mitigate urgent 
health threats. 
Priority Areas 
The multi-dimensional challenges—and opportunities—for creating a more robust 
biosurveillance system are substantial. At the same time, competition for limited resources is 
intense and there is a need to identify priorities. Six priority areas are put forward in The Strategy
to address critical gaps and suggest opportunities for improvement. They are as follows:  
	 Electronic Health Information Exchange – strengthening and expanding upon multi­
directional health information exchanges with healthcare and public health entities.  
	 Electronic Laboratory Information Exchange – strengthening information exchanges 
between and among clinical and public health laboratories and between laboratories and 
public health programs for use in investigations.  
	 Unstructured Data – leveraging digital information (e.g., text and image) that is not in a 
database format for biosurveillance for human health. 
	 Integrated Biosurveillance Information – generating actionable health intelligence by 
increasing access to information resources and synthesizing multiple streams of
information into one coherent picture.  
	 Global Disease Detection and Collaboration – ensuring the United States’ ability to 
contribute to and participate in global disease detection and response through increased 
global capacity and coordinated international action.  
	 Biosurveillance Workforce of the Future – addressing the need for a workforce that is 
available, prepared, and collaborating to adapt to evolving threats and crises.  
Summary
The Strategy represents the foundation for a long-term effort to improve a nationwide capability 
to manage health-related data and information for early warning of threats and hazards, early 
detection of events, rapid characterization, and overall situation awareness so that necessary 
actions can be taken to mitigate health effects. It will be maintained and periodically updated in a 
manner that reflects progress, new ideas, increased knowledge, and shifts in the healthcare 
industry and the related political environment. In this way, The Strategy will unite and integrate 
the work of all interested stakeholders who contribute to and will benefit from the products of 
biosurveillance. 
The Strategy is not intended as a mechanism to dictate policy within agencies, but is written 
under the premise that each agency will plan and implement programs to fulfill its respective 
responsibilities in biosurveillance and maintain performance accountability. Baseline and 
investment-oriented measures will be utilized to evaluate the effectiveness of the activities and 
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programs, allowing agencies to justify their investments, make resource allocation decisions, and 
adjust priorities accordingly.  
Through the implementation of The Strategy, the United States can take significant steps toward 
fulfilling the vision of Biosurveillance in the 21st Century. However, this vision can only be 
achieved through work performed at all levels of government, in healthcare, academia and the 
private sector. Active participation is required of all stakeholders and sustained leadership and 
action is needed at the federal level.
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Introduction 
The scientific foundations of public health surveillance have been advancing rapidly, triggered 
by new technology, increasingly digital data and information, and emerging, reemerging and 
novel health threats that require earlier warning and detection. Containing the spread of disease 
or responding to other human health hazards in an interconnected world requires active vigilance 
for signs of an adverse public health event, rapid validation of its presence, and swift 
characterization so that resources and adaptive strategies can be employed effectively. Greater 
information sharing and strengthened collaborations among public health, healthcare, 
environmental, animal and plant health communities along with partnerships with private sector 
organizations addressing common goals can unleash the power of health-related information to 
prevent, protect, and mitigate the health threats and hazards that Americans face.  
The broader and sophisticated use of information technology, new information sources, and 
analytic techniques holds the potential to accelerate recognition of health threats and improve the 
accuracy of assessments, creating an invaluable resource for health decision-making. With 
greater availability and real-time delivery of digital health information it is possible to create and 
maintain a comprehensive picture of the nation’s health and detect aberrations in normal illness 
patterns faster and more accurately. New opportunities and increasing threats demand a national 
vision for biosurveillance that builds on existing capability and relationships while investing in 
new innovative and science-driven tools and methods. The National Biosurveillance Strategy for 
Human Health (The Strategy) first articulates a vision for enhanced biosurveillance in the 21st 
century, then suggests goals and objectives to be met to make that vision a reality.
Legislative and Regulatory Background 
The impetus for The Strategy can be found in a series of legislative documents. Biosurveillance 
for human health is one component of a larger federally mandated initiative for better 
preparedness and response on a national level. Nationwide preparedness and response is not new, 
although our current technological capacity allows for a greater degree of planning for possible 
health threats and situation awareness during a public health emergency.  
In 2002, Congressional legislation created a bipartisan commission to prepare a complete 
account of the circumstances surrounding the September 11, 2001 terrorist attacks. The 9/11 
Commission released its public report on July 22, 2004. The Commission’s report led to the 
development of Public Law (P.L.) 110-53 (Implementing Recommendations of the National 
Commission on Terrorist Attacks upon the United States Act of 2007), which mandates the 
federal government to develop a system to: 
Rapidly identify, characterize, localize, and track a biological event of national 
concern by integrating and analyzing data relating to human health, animal, 
plant, food, and environmental monitoring systems (both national and 
international). 
Prior to P.L. 110-53, Congress passed and the President signed the Pandemic and All-Hazards 
Preparedness Act (PAHPA) of 2006 (Public Law 109-417). PAHPA focused on public health 
and medical preparedness and response for public health emergencies. The purpose of the 
Pandemic and All-Hazards Preparedness Act is “to improve the Nation’s public health and 
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medical preparedness and response capabilities for emergencies, whether deliberate, accidental, 
or natural.” 
In 2004, the President issued two directives to improve coordination across federal agency bio­
awareness programs. Homeland Security Presidential Directive (HSPD)-9, Defense of United 
States Agriculture and Food (January 30, 2004), charged federal agencies to create a new 
biological threat awareness capacity. HSPD-10, Biodefense for the 21st Century (April 28, 2004), 
called for an integrated and comprehensive warning system that assists in recognizing and 
responding to biological attacks on humans, animals, food, water, agriculture, and the 
environment. HSPD-10 directed the Department of Homeland Security (DHS) to integrate all 
federal agency efforts to create a national bio-awareness system that will detect a biological 
attack at the earliest possible moment and permit initiation of a robust response to prevent 
unnecessary loss of life, economic impact, and social disruption.  
To harness the potential of biosurveillance in the United States the President issued HSPD-21, 
Public Health and Medical Preparedness in October 2007. This directive names biosurveillance 
as one of four critical priorities for improving public health preparedness and charges the 
Secretary of Health and Human Services to: 
“establish an operational national…[bio]surveillance system for human health, 

with international connectivity where appropriate, that is predicated on State, 

regional, and community-level capabilities and creates a networked system to allow 

for two-way information flow between and among Federal, State, and local 

government public health authorities and clinical health care providers.” (HSPD-21, 

paragraph 21) 

Additionally, in December 2006, the United States committed to comply with provisions of the 
revised International Health Regulations [IHR (2005)]. These regulations are designed to prevent 
and protect against the international spread of diseases while minimizing interference with world 
travel and trade. IHR (2005) requires countries to implement core capacities for detecting and 
responding to events, to share information about known diseases and public health events of 
potential international concern, and to collaborate by providing technical, logistical, and financial 
support to ensure compliance.1 The regulations clarify the World Health Organization’s (WHO) 
authority to recommend measures to member states to contain the international spread of disease, 
including public health actions at ports, airports, borders, and on means of transport that involve 
international travel. As the United States is an important contributor to global health, The 
Strategy is mindful of the nation’s responsibilities in planning improvements and connections for 
the global exchange of health-related information. 
The Strategy is a critical component of a comprehensive national approach to biosurveillance. It 
is intended to align with other strategies called for in HSPD-21, such as the recently published 
National Health Security Strategy,2 and other federal government strategies, e.g., Project 
Horizon.3 Additionally, The Strategy supports and supplements plans such as those associated 
1 World Health Organization. International Health Regulations 2005. Geneva: World Health Organization.
2 National Health Security Strategy of the United States of America, U.S. Department of Health and Human 
Services, December 2009 
3 Project Horizon posits a new approach to long-term interagency planning for United States Government (USG) 
agencies whose missions have significant global components to develop realistic interagency strategies and to
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with the National Response Framework.4  The presidential directives along with other related 
agreements and statutory authorities, such as Public Law 109-417 and Public Law 110-53, 
provide a foundation for development of The Strategy.
What is Situation Awareness?
Central to the vision for Biosurveillance in the 21st Century is 24/7, real-time5 situation 
awareness. Adopted from other domains, such as aviation, situation awareness is defined as “the 
perception of elements in the environment within a volume of time and space, the 
comprehension of their meaning, and the projection of their status in the near future.”6  Situation 
awareness is at a premium in work environments where (a) the environment is often dynamic 
and information rich; (b) workers may experience high mental workload; (c) extensive training is 
required; (d) problems are ill-structured; and (e) time is constrained.7 Like pilots taking off and 
landing at busy airports, public health professionals process innumerable bits of data, assign 
meaning, ascertain significance, determine implications, act, and adjust accordingly. In order to 
put together the many pieces of the epidemiological puzzle, health professionals, surveillance 
systems, and data at multiple levels have to be interconnected and integrated. The timeliness goal 
for biosurveillance information in urgent situations is generally considered to be at least daily 
(i.e., near-real-time). 
What is Biosurveillance? 
Biosurveillance in the context of human health is a term for the science and practice of managing 
health-related data and information for early warning of threats and hazards, early detection of 
events, and rapid characterization of the event so that effective actions can be taken to mitigate 
adverse health effects.  Biosurveillance represents a new health information paradigm for public 
health that seeks to integrate and efficiently manage health-related data and information across a 
range of information systems with the primary goal of timely and accurate population health 
situation awareness (SA). 
The nation’s current biosurveillance capability rests primarily in the functions of public health 
surveillance and investigation and is widely distributed across local, tribal, territorial, state, 
federal and international jurisdictions.  While public health surveillance contributes to 
biosurveillance, it is in itself not sufficient to meet the overall information needs for SA across 
the phases of an event (pre-event forecasting, detection, response, recovery).  Other domains and 
identify capabilities in which the government should invest to prepare for unforeseen threats and opportunities that 

the nation will face during the next 20 years. 

4 The National Response Framework presents guiding principles that enable all response partners to prepare for and
 
provide a unified national response to disasters and emergencies; http://www.fema.gov/emergency/nrf/. 

5 For the purposes of this document real-time operation is defined as straight-through processing as seen in trades 

and instant payment processes. 

6 Endsley, M. R. Design and evaluation for situation awareness enhancement. In Proceedings of the Human Factors 

Society 32 Annual Meeting. 1988; 97-101. Santa Monica, CA: Human Factors Society. 

7 Uhlarik J, Comerford, DA. “A review of situation awareness literature relevant to pilot surveillance functions,” 

March 2002. Report No. DOT/FAA/AM-02/3. Available through National Technical Information Service, 

Springfield, VA 22161. 
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disciplines are also required to establish a comprehensive biosurveillance capability, including, 
but not limited to the health of animals and plants, and environmental monitoring.   
The scope and function of biosurveillance includes the following:   
	 All hazards: including biological, chemical, radiological, nuclear and explosives
	 Defined by urgency and potential for multi-jurisdictional interest  
	 Includes urgent notifiable conditions and non-specific and novel health events  
	 Includes ad hoc data gathering, analysis, and application of information  
	 Functions include: Case Detection, Event Detection, Signal Validation, Event 

Characterization, Notification and Communication and, Quality Control and 

Improvement 

	 Supports rapid and efficient discharge of responsibilities for the International Health 
Regulations [IHR (2005)] 
Biosurveillance is dependent on quality data and information.  It should be flexible to balance 
and meet the needs for speed, scale, and specificity.  It musst adapt to the information needs of 
an event, having needed capabilities that extend beyond public health surveillance to support the 
breadth of information requirements across phases of an event.  Biosurveillance also must be 
scalable to allow for the needed granularity of information at the operational level while 
addressing the need for situation awareness at other levels based on roles, responsibilities, and 
assets. A goal of biosurveillance is effective situation awareness. The biosurveillance enterprise
should support the sharing of data across all levels of government but not necessitate the sharing 
of data across all levels for all acute events.  Notification and reporting channels and information 
products should not be unique, but well characterized, explicit, and designed to optimize 
situation awareness among all those with a need-to-know.  As required by the IHR (2005), the 
enterprise should provide the ability to capture unanticipated incidents through reliance on 
human judgment.  A skilled workforce is an underlying requirement for all biosurveillance 
activities.   
The National Biosurveillance Strategy for Human Health 
Because biosurveillance for human health is integral to the Centers for Disease Control and 
Prevention’s (CDC) mission, the Department of Health and Human Services (HHS) assigned 
CDC a key role in coordinating and leading development of The Strategy. In executing this 
charge, CDC established and/or consulted with a number of biosurveillance workgroups and an 
advisory committee comprised of federal, state and local governmental, as well as non­
governmental, stakeholders. Working with advisory groups and stakeholders, version 1.0 (2008) 
of The Strategy was released. Their ongoing consultation has provided input on the current 
version of The Strategy. The Strategy will continue to be updated as requirements, opportunities 
and circumstances evolve. 
The Strategy is intended to guide national interests to: 
	 Implement a national enterprise of complementary systems that provides accurate and 
timely information regarding emerging public health threats to enhance decision-making 
 
                 
 
 
 
 
 
 
 
 
 
 
 
  
 
National Biosurveillance Strategy for Human Health V2.0     February 2010 
Introduction 13
and response in the government, healthcare, and business communities, as well as by
individuals; 
	 Coordinate health-related information sharing both vertically and horizontally across all 
levels of government, jurisdictions and health-related disciplines to improve the 
effectiveness of disease monitoring and response while allowing biosurveillance data to 
remain local where it is best understood and managed;  
	 Leverage and maintain existing relationships between local public health staff and data 
providers; 
	 Engage a diverse consortium of governmental, nongovernmental, academic, and business 
sector stakeholders in the complex national enterprise of biosurveillance for human 
health to build local, regional, and national views of population health; 
	 Optimize resources that support not only biosurveillance information flow but a wide 
variety of public health needs; 
	 Prioritize improvements to existing biosurveillance efforts and infrastructures; 
	 Address all hazards while assuring flexibility and specificity of methods as required to 
monitor and investigate cases and events at the local level; 
	 Embrace a complementary “system of systems” that leverages the robust data collection 
and analyses performed at the local level. Biosurveillance efforts distributed at the state 
and local level allow data to be interpreted, understood, and applied in a local context. 
Local interpretation can be complemented and enhanced by national perspectives that
synthesize multiple data streams and provide a broad picture across jurisdictions.
Development and implementation of The Strategy is dependent on the collaborative efforts of a 
wide range of public health stakeholders which have influence over and will be influenced by The
Strategy’s activities. An example of a key collaboration supported by The Strategy’s goals and 
objectives is cited in the text box below: 
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National Biosurveillance Integration System (NBIS):  NBIS is a national interagency biosurveillance 
integration body led by the Department of Homeland Security (DHS) in accordance with a series of 
U.S. laws and directives. HHS plays a key role as a member of  NBIS because of its expertise in the 
medical and public health arenas. The Strategy, in setting out details of a collaborative approach to 
biosurveillance coordination for human health, is in full accord with NBIS’ efforts to fulfill its 
required integration tasks. The Strategy’s underlying themes of cooperation in support of 
biosurveillance, derived from broad stakeholder input, ensure the document will be used to reinforce 
biosurveillance integration role being played by DHS in accordance with legislative and executive 
mandates.    
As background, DHS was tasked by the President in 2002 to develop a national biosurveillance 
integration system in coordination with appropriate Federal departments and agencies for rapid 
recognition and warning of an intentional dispersal of biological agents.  In 2004, the President 
issued two directives, HSPD 9 and 10, to improve coordination across federal agency bio-awareness 
programs. In 2006, PAHPA required HHS to develop and sustain essential public health security 
capabilities, including disease detection and investigation. Shortly thereafter, Congress codified the 
federal government’s expectations for biosurveillance integration and coordination in Sec 1101 of PL 
110-53. The law directed the Secretary of Homeland Security to “establish, operate, and maintain a 
National Biosurveillance Integration Center (NBIC)” having a mission to (1) “enhance the capability 
of the Federal Government to rapidly identify, characterize, localize, and track a biological event of 
national concern and disseminate alerts and other information to Member Agencies and, in 
coordination with them to agencies of State, local, and tribal governments” and, (2) “oversee the 
development and operation of the National Biosurveillance Integration System (NBIS).” The NBIS 
“system” is currently defined as the joint enterprise consisting of federal departments and agencies 
that participate in biosurveillance development, operation, and governance.  Members contribute 
resources, such as information, analysis, and information technology, which enable identification and 
characterization of biological events of national concern as rapidly as practicable.  Assistant 
Secretary-level guidance for the efficient operation and evolution of the NBIS program is established 
through the NBIS Interagency Oversight Council (NIOC). 
DHS involvement in leading the interagency initiative continues to move forward and remains 
unchanged under the guidance of various HSPDs and public law.  This integrating mission is 
consistent with the Secretary of Homeland Security’s continuing role as the principal Federal official 
for domestic incident management and responsibility for coordinating domestic Federal operations to 
prepare for, respond to, and recover from biological weapons attacks. 
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Examples of other important collaborative efforts include: 
Biosurveillance Indications and Warning Analytic Community (BIWAC): BIWAC's mission is to provide 
an interagency forum for collaborative exchange of information among members regarding indications and 
warning of biological events that could threaten U.S. national interests. Sharing of real and near real-time data 
and the interpretation thereof among members provides actionable information to warn decision makers in 
order to mitigate possible adverse outcomes during rapidly evolving situations. Members include CDC's 
Global Disease Detection Operations Center, HHS’ Office of the Assistant Secretary for Preparedness and 
Response (ASPR), USDA's Center for Epidemiology and Animal Health, DHS' National Biosurveillance 
Integration Center, DOD’s Strategic Command Center for Combating Weapons of Mass Destruction, Northern 
Command, National Center for Medical Intelligence, and the Department of State. 
Integrated Consortium of Laboratory Networks (ICLN): Public health requires coordination of reporting 
requirements from clinical, veterinary, environmental and public health laboratories to state and federal  
agencies. Coordinated reporting requirements across all data sources will reduce the current reporting burden 
on labs and clear the path to define standards and vocabulary for automated exchange of test results. The 
Homeland Security Council established the ICLN and the Department of Homeland Security was assigned the 
Executive Secretariat to promote harmonization and coordination across multiple laboratory networks 
affiliated with federal agencies. The ICLN includes 10 federal departments/agencies: the Departments of 
Agriculture, Commerce, Defense, Energy, Health and Human Services, Homeland Security, Interior, Justice, 
State, and the Environmental Protection Agency. ICLN's mission is to create a U.S. homeland security
infrastructure with a coordinated operational system of laboratory networks that provide timely, high quality 
and interpretable results for early detection and effective consequence management of acts of terrorism and 
other events requiring an integrated laboratory response. 
National Biosurveillance Advisory Subcommittee (NBAS) 
In 2007, Homeland Security Presidential Directive 21 (HSPD-21) called for the establishment of a 
federal advisory committee that includes “representatives from state and local government public 
health authorities and appropriate private sector health care entities, in order to ensure that the 
federal government is meeting the goal of enabling State and local government public health 
surveillance capabilities.” To accomplish this, the Advisory Committee to the Director (ACD), 
Centers for Disease Control and Prevention, established the National Biosurveillance Advisory 
Subcommittee (NBAS) on May 1, 2008 to provide an independent perspective on enhancing our 
nation’s biosurveillance capacity. NBAS is comprised of public and private biosurveillance 
stakeholders from public health, healthcare, academia, and business. As a subcommittee to the 
ACD, the NBAS has helped shape the development of this version of The Strategy by providing 
recommendations and counsel to the federal government through the ACD regarding a broad 
range of issues affecting the development and implementation of a nationwide biosurveillance 
strategy for human health.   
The NBAS divided into Task Forces to develop a report detailing recommendations that would 
have the greatest effect in establishing a well functioning and cost-efficient national 
biosurveillance capacity. The NBAS's report titled: Improving the National's Ability to Detect 
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and respond to 21st Century Urgent Health Threats was unanimously approved by the ACD and 
made public on October 16, 2009.  The report is organized around the following broad and cross 
cutting recommendations: 
	 The Executive Branch must define the strategic goals and priorities of federal 
investments in biosurveillance activities and technologies, implement a plan to achieve, 
fund and periodically assess progress towards these goals. To accomplish this, the White 
House should establish an Interagency Biosurveillance Coordination Committee (“the 
Committee”). 
	 The U.S. National Biosurveillance Enterprise must encompass and enable detection and 
awareness of global health threats.
	 The federal government must make a sustained commitment towards ensuring adequate 
funding to hire and retain highly competent personnel to run biosurveillance programs at 
all levels of government.   
	 Government investments in electronic health records and electronic laboratory data 
should be leveraged to better serve biosurveillance and public health missions. 
	 The federal government must make strategic investments in new technologies to 

strengthen U.S. biosurveillance capabilities.
 
The NBAS is committed supporting the enhancement of the nation’s biosurveillance capability 
in the future by providing advice and creative ideas to federal decision makers in the field of 
biosurveillance. As a major part of that effort, the NBAS will continue to prepare  reports that 
contain recommendations on achieving biosurveillance improvements.  
Planning Principles 
The continued development and implementation of The Strategy is informed by the following 
principles that define how stakeholders will plan and work together:
Build on Current Capabilities and Relationships:  Development of new biosurveillance systems 
should be coupled with the commitment to further develop and sustain the existing systems that 
provide the foundation for biosurveillance at the state and local levels. Clear information 
requirements for a national biosurveillance capability for human health are vital to purposeful 
design and prioritization of enhancement efforts. Cataloging of nationwide biosurveillance 
efforts that comprise the nation’s current capability is necessary to identify gaps. Preliminary 
stakeholder requirements for national biosurveillance for human health and current capability 
assessments were gathered through key stakeholders interviews and working group members at 
the federal, state, local levels. Ongoing stakeholder input will allow for greater specification of 
requirements and current capability.  
Federal, state, and local health departments are at various stages of implementing biosurveillance 
capabilities. Building on their strengths, taking advantage of emerging technologies, and 
expanding the array of biosurveillance information resources is essential to success. State and 
local health departments have established relationships with hospitals, physicians, and other 
healthcare providers to create an operational biosurveillance capability that the nation depends 
on today. Promising practices are emerging that can guide nationwide enhancements. Possible 
strategies will be evaluated for utility and feasibility before being implemented nationally.  
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Establish Standards and Interoperability: Data and technical standards provide the 
specifications for how electronic data are stored and securely exchanged. Interoperability of
platforms is necessary in order to collect, analyze, and visualize data effectively and will enhance 
overall biosurveillance capability by leveraging current systems. Implementation of the 
biosurveillance use-case defined by the American Health Information Community (AHIC) as 
well as standards, specifications, and services advanced by the Nationwide Health Information 
Network (NHIN) and implementation of the Healthcare Information Technology Standards Panel 
(HITSP) standards recognized by the Department of Health and Human Services (DHHS) will 
help address these issues. The Strategy will build upon these relationships, systems, and 
capabilities.
Respect Multi-organizational and Multi-disciplinary Perspectives: An effective biosurveillance 
capability requires the involvement of individuals with different skills and organizations with 
diverse and sometimes overlapping responsibilities. Across government agencies (federal, state, 
local, territorial, and tribal), mechanisms will be pursued to foster a greater exchange of
personnel, share expertise, remove policy barriers to information sharing, and improve 
communications. Frameworks are needed for the multi-directional exchange of information 
between the government and public and private sector entities to set the stage for expanding data 
resources and meeting common interests in protecting the health of Americans.  
Build Federal, State and Local Trust: Principles of governance and data use will be as The 
Strategy is implemented. The governance structure will include Federal, state, local, territorial, 
and tribal representation. The Strategy seeks to optimize and leverage the strengths and 
contributions of all stakeholders and will include active involvement from a broad array of 
expertise. Consensus priorities and solutions will be sought. The Strategy’s implementation will 
provide a supported environment that allows biosurveillance stakeholders to assume tasks, to 
allocate and manage resources, and to develop and enforce internal policies that allow them to 
contribute to the broader enterprise consistent with their interests, authorities, and resources.  
Assure Value for Stakeholders:  The value of a comprehensive and integrated approach to 
biosurveillance comes from exchanging timely, accurate, concise, and actionable information 
among stakeholders resulting in earlier and improved decisions for protecting human health. 
Critical to the quality of information arising from the front lines of public health and healthcare 
(e.g. local levels of clinical and public health practice) is assuring the value of biosurveillance 
information and data before it is aggregated to state, regional, national and international levels. 
In addition, assuring that biosurveillance information exchange is valued by stakeholders during 
everyday responsibilities will improve preparedness for infrequent, high-consequence incidents.  
Ensure Protection of Rights and Authorities:  Biosurveillance data acquisition, reporting, and 
use should be responsive to ethical and legal obligations across government and between 
government and data providers. Ensuring the confidentiality, privacy, security, and appropriate 
use of the public's health information (i.e., data stewardship) is paramount to building trust 
necessary for effective re-use of this information for population health security at local, state, 
federal, and global levels. As information domains for biosurveillance expand, policies and 
agreements surrounding intellectual property will also need to be addressed. Additional work is 
needed to understand the implications of different state and federal legal frameworks for cross­
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jurisdictional information sharing. The work of the AHIC Confidentiality, Privacy, and Security 
Work Group will be leveraged as additional work in this area is undertaken.  
Audience and Key Stakeholders 
This document was written for 
a broad audience that includes 
public health, healthcare, 
academic, and private sector 
stakeholders who contribute to 
and benefit from the products 
of biosurveillance. The 
document assumes that readers 
have varied levels of 
knowledge of the subject and 
thus this strategy includes both 
basic information and advanced content. 
Biosurveillance for complex health emergencies requires collaboration across a diverse network 
of individuals and organizations. This stakeholders network includes Federal Agencies and
State, Local, Territorial and Tribal Governments. The Healthcare Industry and 
International Partners are specifically recognized in legislative documents as core 
stakeholders. While having broader missions the professional communities protecting Animal, 
Plant, and Environmental Health have direct impact on human health security and are 
stakeholders as well.  
Private Sector, Academia, and Community-based Organizations are also vital partners in 
creating the biosurveillance capability necessary to prevent and mitigate urgent health threats. 
Many members of these stakeholder groups are already working together to provide early 
indications and warnings that will inform health situation awareness for decision makers; others 
will require increased engagement efforts. Each of these stakeholders is vital to the development 
and implementation of an effective strategy.  
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Biosurveillance in the 21st Century 
The first decade of the 21st Century has witnessed numerous public health crises that continue to 
challenge the United States and international public health infrastructures. Tuberculosis is 
increasingly resistant to first-line therapies. In an era of globalization and rapid transit, novel and 
emerging diseases, such as SARS, West Nile virus, H1N1 influenza, and the evolving 
antimicrobial resistance of many pathogens, signal the risk of diseases spreading rapidly through 
susceptible populations. Air-, food-, and water-borne disease outbreaks demonstrate the 
vulnerability of society’s most basic needs to chemical and biological hazards, whether natural or 
man-made. Catastrophic natural disasters, such as Hurricane Katrina, made clear the need for 
timely and accurate health information to be shared seamlessly across organizations and 
disciplines to affect a coordinated and effective response.  
Even relatively common exposures demand timely and accurate information to manage 
integrated responses. A derailed freight car carrying chlorine, an accidental release of ammonia 
from an industrial plant, smoke drifting from massive forest fires, errant radioactive materials, 
and numerous other scenarios hold the potential to threaten human health and human lives unless 
addressed quickly and effectively. Containing the spread of such threats and hazards in a 
susceptible and interconnected population requires active vigilance for signs of potential health 
emergencies. When a health emergency does occur, it must be rapidly recognized and 
characterized and its causative factors must be determined to guide strategies and resources for 
an appropriate and effective response. Continuing vigilant monitoring during event management 
or countermeasure intervention is also needed to assure effective outcomes. 
Confronted with these emerging health threats, traditional public health surveillance systems, 
though extensive and sophisticated in many cases, are not set up to fully meet the need for 
comprehensive, near real-time information necessary to guide a rapid response. A new non­
traditional approach based on preparedness, planning and collaboration is necessary to bring the 
full array of biosurveillance activities to bear on addressing such urgent events. New 
technologies are emerging in such fields as data mining, visualization methods, digital open 
source scanning, geo-coding for GIS mapping, electronic health records and laboratory data, 
among many other areas, as noted in the recent NBAS report. These developing capabilities, 
when joined with a better trained and multi-talented workforce, properly organized and 
coordinated, offer hope that the challenges presented by public health threats in the road ahead 
can be met effectively.     
As it continues to evolve, the enhanced 21st Century biosurveillance environment will generate 
increasingly more useful information products that are timely, all-source, analyzed, concise, and 
actionable for federal, state, local, territorial, and tribal government decision-making. Reports 
will be shared through clearly defined and negotiated notification procedures that are rule-based 
whenever possible. Notification and response protocols will balance the tension between rule-
based algorithms, built on critical information requirements that can be automated and timely, 
and broad rules, such as the International Health Regulations [IHR (2005)], that provide the 
flexibility to capture unanticipated incidents through reliance on human judgment.  
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The goal of the biosurveillance effort is to ensure that local jurisdictions have expanded 
capability and capacity to produce a near real-time common operating picture8 of routine and 
emerging acute human health problems that can be easily shared with domestic and international 
entities to inform broader levels of situation awareness in the response community. The vision 
reflects a strategy that is robust and adaptable to future integration of new methods, sources of 
data, and analytical technology that will increase utility to stakeholders. It encompasses: 
	 An all-hazards approach to mitigate the full spectrum of public health emergencies; 
	 An all-population coverage which includes at-risk or special populations (e.g., children, 
older adults) who might be more susceptible to hazards and diseases; 
	 A strengthened and competent biosurveillance workforce and innovative programs for 
maintaining biosurveillance expertise;  
	 A vertically- and horizontally-networked enterprise of complementary systems providing 
biosurveillance capability and multi-directional information exchanges between and 
among domestic and international stakeholders. The complexity of the response to the 
2009 Pandemic H1N1 illustrates how beneficial it is to the control of an outbreak that 
public health officials, healthcare providers, and the public exchange information across 
all relevant professional disciplines,  levels of government, and global surveillance 
networks; 
	 A nationwide, robust and dynamic situation awareness capability with both ongoing and 
ad hoc data collection and real-time analyses and feedback processes to facilitate 
continuous evaluation and adaptation; 
	 Biosurveillance technology to support professional judgment. Electronic systems will 
support collection, integration, data sharing, management, analysis, modeling, and 
visualization of data, but will not replace human interpretation and judgment in an 
evolving situation; 
	 A multi-tiered comprehensive picture of the health of communities formed by the 
integration of all appropriate information that impacts human health, including those 
from animal, plant, and environmental domains;  
	 Enhanced case detection and disease reporting through electronic health information; 
	 Enhanced interoperability between laboratories and surveillance systems including 
nationwide electronic laboratory information exchange; and 
	 Evaluation and judicious integration of newer sources of biosurveillance data, such as 
those derived from news media, electronic discussion groups, call center logs, patient 
chief complaints, web-based social networks, and biosensor data.  
The changing threat environment leaves little room for error or delay before negative health 
effects increase exponentially. Society has little tolerance for government shortcomings in 
protecting the populace from highly visible health threats and events. Biosurveillance provides 
the health intelligence that is the foundation of effective response actions. To understand where 
8 A common operating picture is a single display of information used to support decision making that is dynamic, 
populated with real-time data, and enhanced through methods of data and information visualization.
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enhancements are needed and feasible, it is important to contrast current capabilities with 
biosurveillance requirements. 
Biosurveillance Today
In the United States, the healthcare system is the cornerstone of biosurveillance data including 
reportable disease surveillance. The reportable disease system has observers--primary care 
doctors, emergency departments, infection control professionals and laboratories--already in 
place in every community in the country. These observers make routine required reports and 
alert their local health department to unusual events.  This system also has known disadvantages, 
but few, if any, of the alternatives have the geographic reach of this system.  
In short, the healthcare system addresses all health hazards, it provides nationwide geographic 
coverage, and it produces the most precise health-related information for individuals that is 
subsequently aggregated for population health intelligence. The optimum surveillance approach 
for event detection varies by locality and is affected by such considerations as population 
density, healthcare provider density and distribution, geographic area under observation, nature 
of healthcare provision, availability of laboratories, endemic diseases, and other local factors. 
Nonetheless, case-based surveillance is the benchmark for public health monitoring. It is 
accomplished by clear and consistent criteria to achieve the definition of a case and the 
establishment of a reporting requirement when those criteria are recognized. 
Critical sources of case-based surveillance include, but are not limited to, direct communications 
from clinicians and affected individuals, investigations by public health officials, and reports of 
laboratory data. These sources of data can provide 
specific (i.e., discriminatory) information about A regional epidemiologist launches 
the case-patients and/or pathogens (e.g., a routine daily query of the 
laboratory subtype data) that is required to take searchable multi-user database and
public health action. The historical limitation of learns that in recent interviews 
three patients with reportedthis methodology has been that it requires 
salmonellosis, in three different clinicians to recognize case criteria and actively 
counties, all mentioned eating at report the information to the public health system. 
the same restaurant at a regional The quality of case reporting of notifiable 
mall within two days before onset diseases varies considerably by condition and by of the illness. A record of a citizen jurisdiction. Reporting is often incomplete or complaint about unsanitary 
delayed. These limitations seriously hamper conditions at the same restaurant 
detection and situation awareness, especially in was also received by the state 
the early phases of an emerging health threat. environmental health division. A 
foodborne outbreak investigation isCommunities, like individuals, have a normal 
launched.state of health,. Through routine health 
surveillance and epidemiologic investigations 
public health professionals learn what ‘normal’ looks like in their communities; they are then 
able to then detect deviations. Health professionals also monitor other elements of the biosphere9 
9 The ecosystem comprising the entire earth and the living organisms that inhabit it -- Dictionary.com. 
Dictionary.com Unabridged (v 1.1). Random House, Inc. http://dictionary.reference.com/browse/biosphere
(accessed: March 5, 2010). 
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to assure acceptable rates of exposure and injury. They monitor conditions such as restaurant 
food safety practices, animal diseases, and the need for animal and insect control to prevent 
communicable diseases. They monitor conditions such as industrial materials containment, waste 
disposal, air quality, soil quality, and plant health to prevent toxic exposures. They monitor 
climate conditions, especially temperature extremes, to prevent thermal injuries from heat and 
cold. They monitor occupational conditions such as sound levels, repetitive motion, and 
dosimeter readings to prevent mechanical and radiation injuries. They monitor hurricane 
behavior, earthquakes, and flooding to anticipate health problems from mixtures of microbes, 
toxins, and trauma. When detecting and responding to urgent events with near-real-time health 
information needs, these routine monitoring efforts can be intensified to meet biosurveillance 
needs. During the spring 2009 H1N1 outbreak several traditional influenza surveillance systems 
were successfully able to increase their frequency of reporting, which aided in the response. An 
example of how CDC leveraged existing surveillance systems in that period and CDC’s lessons 
learned from the experience are given in the text box below: 
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Capabilities Today – Biosurveillance Systems in the Pandemic H1N1 (PanH1N1) Response, 
April - June, 2009
During the Pandemic H1N1 (PanH1N1) Influenza outbreak between April and June, 2009, public health 
practitioners throughout the nation worked diligently to respond.  During the response, a broad range of 
surveillance systems, methods, and tools were used to gather, interpret, and communicate urgent health-related 
information; and outputs were used to inform decision making.  The CDC conducted an in-process review of 
the biosurveillance systems, tools, and methods which were utilized for decision making. The results of that 
review provide a snapshot of how surveillance is viewed today within a key federal agency in dealing with a 
real-world response. Major findings of that review are provided below for purposes of illustration: 
• Overall information exchange was good and the response was effective because of relevant and timely
information. This was more a product of ability of experienced and talented people to adapt to the needs of the 
moment rather than the specific systems involved.
• Traditional influenza surveillance systems and laboratory capacity were flexible and scalable for the 
response; limitations in systems in achieving scalability/flexibility were overcome by trained, competent staff. 
• Manual and labor intensive processes had a tendency to degrade as capacity was reached and the event grew; 
they are likely to be limiting factors unless alternatives are prepared. 
• Familiarity was important to data use during the response.  Systems and tools that were not familiar to 
influenza surveillance subject matter experts (SMEs) (i.e., validated and previously interpreted under similar 
conditions) tended not to be used in routine information sharing. 
• While good balance was achieved, some responders expressed a sense that the information available was 
better than the conviction with which it was presented for action. Some of those responsible for presenting 
expressed concerns that the information requirements were continually changing, sometimes unrealistic, and 
demanded more certainty than the data supported.  Stronger commitment to clear critical information 
requirements was urged for planning.
• Visibility of local conditions was a gap given the focal nature of this outbreak. People on the ground are the 
most important factor in getting specific and valid data.  Epi-Aids and related field work yielded outstanding
information. 
• The international influenza data were held in very high regard.  This appears to have been a combination of 
quality staff, quality relationships, and effective partnerships that integrated and reinforced critical thinking 
from multiple different perspectives.
• Problems in data sharing between states and federal agencies were a result of manual systems, duplicate 
entry requirements, and a strong desire to see federal agencies abide by the standards espoused in PHIN and 
notifiable disease surveillance.  Automated systems were viewed as performing well.  Manual linkage of 
laboratory and epidemiology data is a serious impediment that requires more long-term attention (e.g.,
establishment of a national patient identifier). 
• Peer-to-peer (horizontal) communication was better than vertical communication. The more federal agencies 
can help partners define the critical information requirements needed to make decisions that are in scope for 
them, the less likely they will be to seek information not relevant to their role. 
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In the past decade, the science of surveillance has advanced rapidly in response to the need for 
early warning and detection of emerging, reemerging and novel health threats and hazards. New 
techniques are being introduced from diverse scientific fields to improve case-based reporting 
and situation awareness, as well as methods to identify and characterize events of public health 
interest that are not directly reportable as individual cases (e.g., food-borne outbreaks). 
Expanding dramatically beyond traditional notifiable disease reporting, methods now include 
managing data in electronic health records, electronic laboratory information exchange, 
environmental sensors, and health event indicators such as pharmacy sales data and call center 
logs. 
Currently, these inputs provide an inconsistent mix of accuracy and timeliness. Communication 
between laboratorians and epidemiologists is sometimes poor and in many cases still manual, 
(e.g., in person or via telephone, and paper-based). Professionals within the public health system
may have pieces of information that responders need in order to achieve accurate situation 
awareness. Notifiable disease reports are often not timely. Syndromic surveillance systems can 
be timely, but may lack specificity needed to validate and interpret signals and cues. Signals 
generated by these systems need rapid follow-up investigation and coordination with healthcare 
providers for the systems to provide a differential improvement over clinician-only 
surveillance.10 
While today’s U.S. biosurveillance capability has demonstrated effectiveness, as seen in the 
recent response to the spring 2009 H1N1 outbreak, too often success is dependent on the 
variability of human flexibility and effort; major vulnerabilities remain in the systematic ability 
to rapidly detect and mitigate health emergencies. Biosurveillance information still is not 
integrated, it does not flow as quickly or as efficiently as is necessary, and the trained workforce 
is in critically short supply. 
Requirements for Biosurveillance 
Successful biosurveillance capability must accomplish the following functions:  
Case detection—discovery of the existence of a single instance of a specific disease or
exposure. A front-line biosurveillance activity, it is typically accomplished as a by-product of 
routine medical or veterinary care, laboratory work, or via an astute observer.  
Cluster detection—continuous analysis of health-related data to detect unusual patterns of 
conditions that may signal an outbreak. Cluster detection seeks to identify patterns in volume 
surveillance and unstructured data, rather than case reports, to identify potential events.  
Signal validation—confirmation processes that ensure that cases, clusters, signals and other 
such cues represent acute public health events that require a response. These may be labor and 
time intensive.  
Event characterization—includes the range of processes that support case investigation and 
tracing and are linked to early event detection to decipher and specify the causative biological 
agent, source, route of transmission and other characteristics of an outbreak or event. These 
10 Steiner-Sichel L, Greenko J et.al. Field investigations of emergency department syndromic surveillance signals— 
New York City. MMWR. 2004. Sept 24;53 Suppl:184-9.  
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characteristics guide effective response actions, including the treatment of victims and the 
institution of control measures to prevent additional cases.  
Notification and communication—processes, including notifiable disease reporting, that ensure 
that those with a need and right to know have information (event details as well as response 
guidance) as soon as possible, and all users understand their responsibilities for use and 
management of the information. State statutes, laws, regulations and, less frequently, ordinances 
at the local or county level determine which diseases and health conditions are reportable to 
public health authorities. These reporting requirements enable healthcare providers, laboratories, 
hospitals and other care facilities to report patient information to public health authorities so 
those authorities can investigate the source of the occurrence and prevent additional spread of 
disease. The reporting requirements may include name reporting, demographic information, and, 
in some instances, clinical information and laboratory results. Current reporting mechanisms
include mail, phone, fax, and secure electronic reporting.  These processes also support the mass 
administration of prevention and treatment measures, adverse event detection, and isolation and 
quarantine tracking. 
Quality control/ improvement—ensuring data management, including protecting the privacy 
and confidentiality of biosurveillance data, and monitoring the system through performance 
measurement to confirm that objectives are being met. 
These functions require capabilities at the state and local levels where follow-up investigation 
can take place, domain knowledge can be incorporated for accurate interpretation, information 
quality feedback loops can be executed, and ultimately, effective response actions can be taken. 
Close working relationships, resourcing, and training support will be needed to ensure a robust 
and effective biosurveillance capability resides at the state and local levels across the U.S. 
Towards Implementation 
The multi-dimensional challenges – and opportunities -- for creating a more robust 
biosurveillance system are substantial. The social and economic costs of recent disease outbreaks 
underscore the importance of biosurveillance in detecting, preventing, and mitigating adverse 
human health events. At the same time, competition for limited resources is intense. 
Consequently, there is an immediate need to identify priority areas. Six priority areas are put 
forward in The Strategy to address critical gaps and suggest opportunities for improvement. 
These are as follows:  
	 Electronic Health Information Exchange – to strengthen and expand upon multi­
directional health information exchanges with healthcare and public health entities. This 
priority includes information available today and that will be available in the future as 
healthcare systems evolve.  
	 Electronic Laboratory Information Exchange – to strengthen information exchanges 
between and among clinical and public health laboratories and to improve integration of 
laboratory and epidemiologic data.  
	 Unstructured Data – to leverage digital information (e.g., text and image) that is not in a 
database format. Sources of unstructured data include digital news media and discussion 
forums as well as digitally-stored information in health departments and the healthcare 
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system that capture notifications and queries about potential events of public health 
concern.
	 Integrated Biosurveillance Information – to generate actionable health intelligence by 
increasing access to information resources and synthesizing multiple streams of
information into one coherent picture.
	 Global Disease Detection and Collaboration – to ensure the United States’ ability to 
contribute to and participate in global disease detection and response through increased 
global capacity and coordinated international action.
	 Biosurveillance Workforce of the Future – to address the need for a workforce that is 
available, prepared, and collaborating to adapt to evolving threats and crises.
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Priority Areas 
Electronic Health Information Exchange11 
Health information technology (HIT) and electronic health information exchange, including 
electronic health records (EHRs), have the potential to accelerate timely and accurate sharing of 
health data between clinical care and public health practice settings. Healthcare information 
provides the most specific and direct representation of the health of the nation’s communities. At 
present the healthcare system has four critical roles in biosurveillance: 
1) report notifiable diseases and clusters of suspicious illness to state and local health 
departments;  
2) provide automated data streams that can be used to recognize and monitor outbreaks; 
3) assist health investigators through the provision of clinical information from patient 
medical records, screening services, diagnostic results, and other sources; and  
4) monitor patient and worker health and safety within its own facilities (especially 
hospitals and long-term care facilities). 
Like biosurveillance, the practice of medicine is information intensive. The healthcare system
records many types of data for every patient encounter. Access, however, is a significant barrier 
to the use of healthcare data for biosurveillance. The data needed for early detection and rapid 
characterization of an outbreak or other adverse human health event are stored in a variety of 
locations, often in paper-based form. Even when data are recorded electronically (as is typically 
the case for laboratory test results and radiology exams), they are encoded in non-standardized 
formats that present a barrier to data use and integration. Other data, such as symptom and 
physical exam data, are often recorded in unstructured formats (e.g., text strings). Data may also 
be of poor quality (e.g. when incorrect ICD-codes are used). Clinical care and public health 
practitioners exchange information primarily via fax, email, and phone for case, outbreak, and 
other adverse human health events reporting.  
Progress toward expanding the use of EHRs offers promise for eliminating many of the existing 
inefficiencies in health care and public health settings.  At its most basic level, EHRs convert 
paper charts to electronic ones, reducing paperwork, helping prevent medical errors, and adding 
efficiencies to the transmission of information such as prescription data.  They also give health 
care providers a fuller picture of the patients’ health by integrating their medical histories and by 
tracking more efficiently key aspects of patients’ ongoing medical condition and treatment.  
11 For the purpose of this document, electronic health information exchange is defined as the sharing of digitized 
human health data and information according to nationally recognized standards among organizations that can 
utilize the information to improve individual and community health security.
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Enhanced electronic information flow to public health practitioners generated from EHRs can, in 
turn, help in the management of risks to entire groups and in the development of preventive 
measures that have broader applicability. 
Health information technologies have been introduced to assist almost every aspect of medical 
practice, including scheduling, ordering of tests, recording of clinical observations, and 
processing billing and claims. Some of these departmental systems are widely deployed; others, 
such as electronic health records and e-prescribing systems, have more limited adoption. The 
success of electronic health information exchange is dependent on linking all those engaged in 
the care of the patient, whether individuals or communities, together in secure and interoperable
environments. Widespread deployment of HIT systems, including the development of networks 
that support electronic health information exchange, while adhering to security and privacy 
standards, is the essential foundation to realizing clinical data’s full potential for biosurveillance.  
Mutual benefit is possible through the coordination of biosurveillance objectives with HIT for 
patient treatment and healthcare system improvement. Arming healthcare systems and health 
departments with strengthened case-finding approaches and bidirectional, real-time information 
about health threats and events in the community will allow health professionals to effectively 
adapt patient interventions to changing conditions and thus provide the best care possible. 
Aggregated population-based information will facilitate clinical research on new treatment 
options and implementation of quality improvement programs. Nonetheless, challenges exist to 
incorporating biosurveillance requirements into the information architecture of medical business 
systems and the workflow of medical practice. The business model for medical practices 
constrains implementation of new information system requirements until benefits outweigh the 
cost of installation and support. A favorable business case is needed. 
Public support for e-health efforts is necessary to leverage the potential of electronic health 
information. Privacy protection and security measures are key components of success in the 
development and sustainability of electronic health information exchange and HIT. Ongoing 
successful experiences with the secure transfer of standardized electronic healthcare records are 
building the trust necessary for that support.  
In an enhanced biosurveillance environment the healthcare system will exchange significantly 
more data and services with public health and will do so in real time. This trend is already 
unfolding in many jurisdictions in the United States and abroad. In support of this exchange, 
public health programs and professionals will assure security and appropriate use of the 
information, minimize the burden, and transmit information helpful to clinicians, such as 
automated support for reporting requirements, guidance on diagnosis and management, and 
situation awareness information.  
The Nationwide Health Information Network (NHIN) and the standards for biosurveillance 
published by the Health IT Standards Panel (HITSP) are expected to serve as the foundation for a 
nationwide exchange. Interconnected networks will share common services and adhere to 
standards and requirements to enable interoperability. The enriched data-sharing environment 
will allow both clinical and public health professionals automated processes for entering 
information, access to health information when they need it, automated analyses that support 
notifiable disease detection and outbreak cues, query abilities for additional investigation when 
warranted, and feedback loops to validate findings and enact countermeasures. 
Goals for this priority area include: 
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Goal A. Create Nationwide Capability for Health Information Exchange 
A nation-wide data framework of health information sharing could enable the public health 
community to store data locally, in state and local public health departments and within the 
healthcare system, and allow stakeholders, including the federal government, to access and 
analyze those data with appropriate permissions. There are multiple technical approaches to such 
a data model including grid technology, service oriented architecture, and lightweight data 
integration. These approaches should be explored through collaborative proof-of-concept 
projects.
Proof-of-concept projects for different technological approaches for information sharing between 
existing health information databases are currently underway. Efforts are already underway at 
the national level to identify standards for HIT systems to ensure they are interoperable and have 
the necessary security and privacy capabilities. Promoting standards-based, interoperable 
technologies and certification may help overcome provider concerns and speed HIT and 
electronic health information exchange development. A large body of work exists that can be 
directly applied towards integrating clinical data into biosurveillance. The number of 
collaborative health information exchange initiatives at the state, regional, and community levels 
has grown considerably with a nearly 40 percent increase over 2008 in the number of advanced 
or operational initiatives.12 
Several initiatives have been undertaken within the Department of Health and Human Services 
(HHS), Office of the National Coordinator for Health Information Technology (ONC) to provide 
incentives to healthcare entities. Through the American Recovery and Reinvestment Act of 2009 
(ARRA), the Centers for Medicare and Medicaid Services (CMS) is authorized to provide 
reimbursement for healthcare providers who adopt electronic health records (EHRs) meeting 
“Meaningful Use” criteria. The reimbursements begin in 2011.  By 2015, providers are expected 
to have adopted meaningful use of EHRs or face financial penalties.  
Meaningful use of EHRs centers on the idea of improving clinical care through exchange and 
utilization of health information.  As the definition of meaningful use evolves, it is essential that 
public health is an active participant to ensure that biosurveillance needs are addressed.  This has 
further implications than just financial incentive programs for adoption, as meaningful use 
criteria may be used to define certification criteria for EHRs in the future.  EHRs must have the 
capability to exchange information with public health without an additional burden on healthcare 
providers. 
As health policy facilitates the adoption of HIT, the need for measurement is critical.  ONC has 
partnered with George Washington University & Massachusetts General Hospital / Harvard 
Institute for Health Policy to measure the state of EHR adoption and determine the effectiveness 
of policies to increase adoption of EHRs and interoperability.    
In addition to financial incentive programs to promote adoption of meaningful use of EHRs, 
grants are available under the ARRA to accelerate electronic exchange of information.  Two 
priority areas have been released as of August 2009:  1) Health Information Technology 
Extension Program and 2) State Health Information Exchange Cooperative Agreement Program.  
12 eHealth Initiative. Sixth Annual Survey of Health Information Exchange. Migrating toward Meaningful Use: The 
State of health Information Exchange. 2009. http://www.ehealthinitiative.org/HIESurvey/. Accessed March 5, 2010. 
 
  
 
 
 
 
 
 
 
 
National Biosurveillance Strategy for Human Health V2.0     February 2010 
Priority Areas: Electronic Health Information Exchange 30 
The Health IT Extension program provides grants to establish centers to support and accelerate 
adoption of meaningful use of EHRs by healthcare providers.  These Health IT Regional 
Extension Centers will offer technical assistance, guidance and information on best practices to 
healthcare providers. The State Health Information Exchange (HIE) Cooperative Agreement 
Program provides grants to states or their designees to establish HIE capabilities in their 
jurisdictions. These efforts to build connectivity among health care providers and hospitals will 
improve quality of care.  Both of these grant programs, and those yet to be announced, have the 
potential to enhance biosurveillance capacity and require that public health needs be incorporated 
from the outset. 
Objectives: 
1.	 Ensure implementation of standards and specifications to support bidirectional 
exchange of biosurveillance data between clinical care, laboratories, and public health.
2.	 Provide input from a public health perspective in defining meaningful use of EHRs to 
assure biosurveillance needs are met.
3.	 Support incentive programs (e.g., reimbursement policies) that facilitate adoption of 
meaningful use of electronic medical record systems, to enable electronic health 
information exchange. 
4.	 Encourage widespread adoption of meaningful use of electronic health record systems. 
5.	 Create robust, interoperable linkages between clinical care, laboratories, and state/local 
public health, leveraging existing efforts and infrastructure as appropriate.   
Goal B. Strengthen Surveillance Processes and Notifiable Disease Reporting 
Mechanisms, Including Electronic Laboratory Results Reporting 
Notifiable disease reports, including reportable disease laboratory findings and vital statistics, are 
among the most enduring types of data collected systematically for biosurveillance purposes. 
Automated and standardized electronic reporting processes for notifiable diseases can also 
greatly enhance the nation’s biosurveillance capability.  Electronic laboratory results reporting 
(ELR) has been shown to greatly increase the speed with which notifiable disease reports are 
received. Laboratory information exchange is a critical component of health information 
exchange, and so is addressed here. It also appears in The Strategy as its own priority area to 
underscore the extent to which laboratories are fundamental to biosurveillance and to recognize 
the importance of linkages to laboratories testing non-human specimens (e.g., environmental 
samples and animal specimens).   
Advancing the timeliness and accuracy of reportable laboratory findings through automated 
electronic reporting from all clinical laboratories and advancing the timeliness and accuracy of 
death records through electronic registration in the United States are within reach. Death is the 
quintessential health metric and has served as the foundation of surveillance since the origins of 
public health. Work also needs to be done to improve, expand, and enhance biosurveillance 
systems for priority exposures and health events, for example, improve surveillance for chemical 
and radiologic exposures, improve the speed and quality of coding and reporting of nature-of­
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injury and external-cause-of-injury data from emergency departments, and improve numbers of 
states covered by poison control center surveillance. 
Public health must continue to work with healthcare and HIT vendors to ensure their applications 
are biosurveillance-enabled, having the capability to collect and exchange data at the point of 
care as part of the normal workflow. Emphasis will also be placed on collaboration to 
consolidate requests for clinical data and minimize the burden of collection. As adoption of HIT 
and electronic health information exchange widens and as healthcare systems become more 
integrated opportunities will arise to exchange additional data. Agreement on and widespread 
implementation of an expanded set of data elements, policies for data sharing that build trust, and 
mutually agreed upon business models will accelerate data exchange between clinical and public 
health systems. Additional functionality to enable decision support and to enable bidirectional 
communications among front-line clinicians and public health will also be needed.  
Electronic reporting of cases of disease from EHRs has been shown to improve timeliness and 
completeness of reporting from healthcare entities.  Throughout the past year, work has been 
undertaken by the Council of State and Territorial Epidemiologists (CSTE) and CDC to 
standardize data elements and case detection algorithms for identification and reporting of
nationally notifiable conditions from healthcare entities to local and state public health.  
Implementation guides are being developed to enable electronic exchange of these data.  This 
work, combined with widespread adoption of EHRs, has the potential to improve case detection 
capabilities for reportable public health conditions.  Further development, testing, and 
implementation of algorithms and data exchange standards are necessary to enhance capabilities.  
The benefits of having a national or global biosurveillance capability may be readily apparent on 
a societal level, although not at a healthcare businesses level. Both understanding and 
articulating the “value proposition” for healthcare providers are critical to forming productive 
collaborations. 
Objectives: 
6.	 Develop a compelling business case for automated information exchange between public 
health and healthcare. 
7.	 Evaluate real-time data management approaches for electronic health record systems to 
support case reporting, syndromic, and exposure data. 
8.	 Support timely and accurate case detection and disease reporting capabilities in all 
clinical settings for all priority exposures and health events. 
9.	 Develop decision-support tools for sharing biosurveillance information with clinical 
care providers (through work with software vendors) and prompting providers to 
request consultation from public health professionals. 
10. Enable electronic reporting systems, with emphasis on the following areas: electronic 
real time death registration, automated transmission of laboratory reportable findings, 
and electronic real-time reporting from healthcare providers.
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11. Establish informational architecture for the national biosurveillance capability, 
including but not limited to, interfacing with the Nationwide Health Information 
Network (NHIN), other federal networks and existing state and local health networks. 
Goal C. Strengthen Biosurveillance Communications in Healthcare   
Web-based tools and voice and text messaging systems are used by stakeholders in healthcare as 
convenient means of providing alerts and notifications of health issues. Enhanced biosurveillance 
capability must leverage convenient mechanisms for information sharing to maximize the value 
of biosurveillance findings. More development and evaluation is needed to establish the most 
effective mechanisms.  
Objectives: 
12. Evaluate existing approaches for advancing bidirectional communications between 
healthcare and public health. 
13. Initiate and support pilot programs for improving communications for biosurveillance 
alerting, notification, and related actions.  
14. Develop approaches to interface with existing networks and health information 
exchanges at all levels. 
Goal D. Address Health Information Privacy, Security, and Use  
Consumer and provider trust are key to the success of electronic health information exchange. 
Privacy and security policies and standards are not applied consistently across healthcare entities 
at this time. Current state and federal privacy law requirements are inconsistent, further 
inhibiting electronic exchange. Privacy laws that govern information exchange and requirements 
for data disclosure vary across states and jurisdictions (e.g., federal and state). Requirements may 
vary by data type (e.g., general health, mental health, or infectious disease); purpose of use (e.g., 
treatment, public health reporting); and mechanism for compliance (e.g., ink signature, paper 
form, verbal). State privacy requirements are scattered into different chapters of legislation and 
regulation. Some are specifically written for a paper-based system.13 Federal and state agencies 
must work together to better understand what privacy laws are supportive or prohibitive of 
electronic health information exchange and address unintended impediments these laws present.  
New activities should build upon the ongoing work of many organizations,  such as: The 
American Health Information Community Confidentiality, Privacy, and Security Work Group; 
Health Information Security and Privacy Collaboration; American Medical Informatics 
Association; American Quality Association; Connecting for Health; eHealth Initiative; National 
Committee on Vital and Health Statistics; the Workgroup for Electronic Data Interchange; and 
the Nationwide Health Information Network Data Use and Reciprocal Support Agreement 
Workgroup. 
13 State Alliance for e-Health. Accelerating Progress: Using Health Information Technology and Electronic Health 
Information Exchange to Improve Care. Washington, DC: National Governors Association Center for Best
Practices, 2008. http://www.nga.org/Files/pdf/0809EHEALTHREPORT.PDF. Accessed March 5, 2010. 
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Objectives: 
15. Create a set of common principles and policies for use of electronic clinical data.  
16. Align policies and laws to support intra- and interstate data exchange while ensuring 
appropriate consumer protection. 
17. Define data access, data use and data sharing policies to ensure the availability of
biosurveillance information to identified and authorized users.
Goal E. Establish a Governance Body to Guide Electronic Health Information 
Exchange  
Leadership from government and the private sector is critical to the success of HIT and 
electronic health information exchange initiatives. A key ingredient in formulating these 
initiatives is building the trust needed to facilitate collaboration. Stakeholders (e.g., payers, 
providers, and consumers) engaged in e-health activities represent diverse, sometimes opposing 
viewpoints and have varying needs and missions. Visible and sustained government support that 
recognizes the value of HIT and electronic health information exchange in enhancing 
biosurveillance outcomes will help improve coordinated action. 
As the National Health Information Network (NHIN) evolves and moves into production, 
operational policies, data use and reciprocal support agreements, and a model for governance 
will be required. NHIN policy and governance teams will address these requirements.  The 
NHIN governance model should be leveraged to serve as a governance for both Electronic 
Health Information Exchange and Electronic Laboratory Information Exchange outlined in this 
document, as appropriate. 
Objectives: 
18. Ensure leadership and support for HIT and electronic health information exchange 
exists at all levels of government. 
19. Establish state-level roadmaps articulating state visions and strategies for electronic 
health information exchange using a collaborative approach involving appropriate 
stakeholders, including state public health departments.. 
20. Establish forums for the sharing of best practices, protocols and lessons learned.  
21. Implement social and technical platforms to enable scientific collaboration, 
standardization and informatics development. 
22. Explore data use policies that address privacy, security, data ownership and 
stewardship, and liability protection for data providers. 
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Electronic Laboratory Information Exchange 
The intent of electronic laboratory information exchange is to improve timeliness of reporting, 
accuracy, completeness, and availability of laboratory data for use by those who need the 
information for investigation and decision-making. Laboratory-based testing and surveillance 
provides a critical foundation for effective biosurveillance practice. Addressing the exchange of 
laboratory information within the human health domain is the initial focus of this priority area. 
Strengthening connections and promoting the use of data standards among laboratories (i.e., 
public health, clinical) and between laboratories and public health organizations across 
jurisdictions (local, state, regional, national, and global) and domains (human, animal, plant, 
food, and environmental) is important to biosurveillance. 
The value of laboratory information lies in its diagnostic capability and key role in identifying 
cases and events of public health significance. Electronic data exchange between clinical 
laboratories and public health has demonstrated the potential to improve the timeliness of event 
detection and increase the number of reports received.14 
Critical stakeholders in laboratory information exchange for human health include clinical 
laboratories (commercial and hospital), public health laboratories (local, state, and federal), 
clinicians, as well as public health programs (local, state, and federal) that use laboratory 
information for diagnosis, case and event detection, investigation, and confirmation. This 
community of stakeholders must be able to share information seamlessly in a manner that 
supports their specific business practices. 
Within this priority, electronic laboratory information exchange has two critical components, 
exchange of information between laboratories for optimal laboratory practice and between 
laboratories and public health stakeholders for use in investigations and responses. Protocols and 
policies should be in place to ensure that the use of this information in investigations and 
responses - which facilitate a rapid response - adheres to privacy and confidentiality 
requirements.  
First, laboratories must be able to exchange test orders and results with other laboratories. This 
includes sharing information related to the ordering of tests and reporting specific findings (e.g., 
organism identified, method performed, instrument used), as well as test interpretation (e.g., 
normal ranges). This exchange should occur electronically between laboratory information 
management systems (LIMS) (also known as laboratory information systems, or LIS). Such 
laboratory-to-laboratory exchanges are essential when large numbers of tests are performed. It is 
also critical in a continuity of operations situation in which one or more public health 
laboratories must support testing for a laboratory that is unable to perform testing for any reason. 
The spectrum of testing conducted within laboratory systems varies, lending complexity to 
messaging needs around test orders and results.  
14 See, for example, Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. Statewide system of
electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional 
methods. JAMA 1999;282(19):1845-50; Häyrinen K, Saranto K, Nykänen, Definition, structure, use and impacts of 
electronic health records: a review of the research literature. Int J Med Inform 2008;77:291-304; Moore KM, Reddy 
V, Kapell D, Balter S. Impact of electronic laboratory reporting on Hepatitis A surveillance in New York City. J 
Public Health Manag Pract 2008;14(5):437-441;  
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Equally important, public health 
professionals must be able to receive 
laboratory results to support detection, 
The 2007 State of Technology Adoption confirmation, and investigation of case 
Survey, conducted by the Association ofreports and outbreaks or other events of Public Health Laboratories (APHL), surveyed 
public health significance. This should the LIMS capabilities of state and local public 
be accomplished by automated transfer health laboratories. Among the 68 
of electronic laboratory results from a respondents, only 57 percent reported having
a functional LIMS. Among the 39 laboratoriesLIMS to public health surveillance 
with a functional LIMS, 62 percent conductsystems to reduce the time and labor 
automated electronic data exchange with an involved and to facilitate epidemiologic external partner such as CDC, another state 
analyses of laboratory data. laboratory, or a private laboratory. Seventy-
four percent of labs with a functional LIMS However, the transition from paper to conduct automated electronic data exchange 
electronic reporting has been slow with a state epidemiology program, and 62 
despite a national movement to adopt percent exchange data using standard 
standards for exchange. Many vocabulary, such as LOINC® or SNOMED.15 
(Personal communication. Patina Zarcone,laboratories lack a modern LIMS to 
Association of Public Health Laboratories, manage, track, and share laboratory 
APHL 2007 State of Technology Adoption results. Consequently they must provide Survey)
reports via paper or other methods that 
require manual and repetitive data entry. 
These challenges exist at all levels (local, state, and federal), both for clinical and public health 
laboratories. Effective information technology tools and data standards exist to help address 
these challenges, but barriers to adoption persist, including limited resources and other 
organizational priorities.
Laboratories that have implemented LIMS face additional challenges. Data standards for 
messaging vocabulary have been established, but their application remains inconsistent. The use 
of different messaging formats and coding at the hospital and private clinical laboratory levels 
provides a striking example. Even when the same standard is used (e.g., HL7 2.3.1 for messaging 
or LOINC® for vocabulary15), how the standard is applied may vary slightly from laboratory to 
laboratory and across jurisdictions. This may include variability in the specific standards or 
codes used to represent the same concept, as well as the level of detail that is provided. 
Limitations of LIMS systems may also prevent laboratories from adhering to standards.  
15SNOMED CT (Systematized Nomenclature of Medicine--Clinical Terms) is a comprehensive clinical terminology
originally created by the College of American Pathologists and, as of April 2007, owned, maintained, and 
distributed by the International Health Terminology Standards Development Organisation. 
http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html.   Accessed March 5, 2010.  LOINC® (Logical
Observations Identifiers, Names, Codes), is a clinical terminology important for laboratory test orders and results
produced by the Regenstrief Institute. LOINC is one of a suite of designated standards for use in U.S. Federal 
Government systems for the electronic exchange of clinical health information.
http://www.nlm.nih.gov/research/umls/loinc_main.html. Accessed March 5, 2010.
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Many public health programs lack biosurveillance systems capable of automatically populating 
case reports with electronic information from laboratories. The lack of connectivity makes 
duplicate data entry and manual cross-matching of records necessary. In addition, there are 
multiple stand-alone disease-specific systems with no ability to exchange laboratory information. 
Some were developed prior to widespread availability of standards and now are the sole system
supporting vital programs. Facilitating interoperability of these systems would result in more 
efficient and effective data management across public health programs and jurisdictions. 
The Public Health Laboratory Interoperability Project (PHLIP) advocates for collaborations that 
strengthen the public health laboratory community.  The project includes components related to 
laboratory data vocabulary, messaging, security, and architecture and building community and 
collaboration around the critical issue of laboratory data messaging.  This collaborative has 
reached a level of maturity where it has evolved from proof of concept status to production status
and the project is poised to achieve bi-directional data messaging to and from CDC and its state 
laboratory partners. The public health impact of being able to effectively and efficiently share 
laboratory data electronically is fundamental to planning public health strategies and responding 
to all public health threats. 
Challenges related to electronic laboratory information exchange have eluded quick solutions. 
Still, incremental progress has been made in setting national standards for interoperability, 
security, and data terminology; providing in-field state/local consulting expertise and training; 
and providing federal guidance on strategic initiatives and helping to procure funding. Solutions 
to challenges will consist of approaches that advance and expand work currently in progress 
while acknowledging the need for progressive implementation. Key goals for this priority area 
include:   
Goal A. Ensure the Electronic Management and Exchange of Laboratory Test 
Orders, Specimens, and Results Information 
Sharing electronic test orders and results across laboratories is effectively accomplished today in 
some but not all locations. There has been considerable work on the development of standards 
for electronic messages and vocabulary for laboratory information, but the translation of these 
into practice has not been coordinated. Multiple stakeholder groups implement coding schemes 
and develop localized standards to meet their needs, which results in disparate implementation.  
An electronic mechanism for accepting test orders, sharing specimen information, tracking and 
reporting results would provide for more rapid, accurate, and efficient surveillance and 
consultation. Infrastructure investments are needed at all levels (local, state, federal) that 
contribute to the public health system (clinical, public health, and other laboratories) to develop 
LIMS systems capable of sharing this information. Investments are needed at local, state, and 
federal laboratories to assure that capabilities of the nationwide network of public health 
laboratories can be shared in a timely manner with those who are managing patients and the 
community response. Successful projects that are showing progress toward the consistent 
application of standards should be identified, promoted, and advanced.  
Objectives: 
23. Engage stakeholders to identify and resolve gaps in standards, share best practices, and 
promote consensus for implementing data standards. 
 
     
 
 
 
 
  
 
 
 
 
 
 
Investment at the state and local level has 
demonstrated success and resulted in significant 
progress. In 2007, the National Electronic 
Laboratory Reporting (ELR) Teleconference Group 
(sponsored by Council of State and Territorial 
Epidemiologists) conducted a survey of 50 states, 
one territory and 5 U.S. metropolitan areas on the 
status of electronic laboratory results reporting to 
public health organizations. Thirty-eight 
respondents were operational at some level, 14 of 
38 were 50-100% operational. Fifty percent of 
respondents were receiving reports electronically 
from their reference public health laboratory. 
Eighteen of 52 respondents with local health 
departments in their jurisdiction reported being 
able to route the data to those users. 
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24. Identify incentives and ensure consistent application and use of standardized 
vocabulary and messaging, including standardized data elements for electronic 
laboratory reporting.
25. Engage commercial vendors and promote the implementation of LIMS in laboratories 
for functions of particular importance to biosurveillance for human health.  
Goal B. Ensure Reportable Laboratory Information is Combined Electronically
with Clinical and Epidemiological Data 
Laboratory reporting is required in all states for test results related to state reportable and 
nationally notifiable conditions. This information, when combined with other epidemiologic 
data, forms the basis for public health investigations. Building a public health case record is a 
component of case investigation that includes laboratory and clinical data as well as risk-factor 
data about the case. Although it is not 
expected that lab results would be 
accompanied by clinical information, 
many laboratory results that are 
messaged to public health entities do 
not contain enough information for 
public health professionals to begin an 
investigation (e.g., unique patient 
identifier shared to link laboratory data 
efficiently with epidemiologic data). 
One of the challenges of the 2001 
anthrax attack response was 
integrating laboratory test orders and 
results with additional clinical and 
epidemiologic data held by infectious
disease experts. In an effort that will 
facilitate interoperability between laboratory and epidemiology programs, the Council of State 
and Territorial Epidemiologists (CSTE), in partnership with CDC, has rewritten surveillance 
case definitions for Nationally Notifiable Conditions (effective January 2010) to include 
specifications for laboratory results. Efforts will: 
	 Promote and strengthen interoperable platforms for information exchange; 
	 Advance consistent application of standards in the design of public health surveillance 
information systems to ensure that surveillance systems are capable of processing, managing, 
manipulating, and displaying electronic laboratory information in an automated way; 
	 Identify and address unique types of data files that need to be shared that may not yet utilize 
data standards (e.g., text string results, pulsed field gel electrophoresis (PFGE) pattern files); 
	 Explore identification strategies (e.g., the creation of globally-unique patient identifiers), to 
facilitate the early linkage of laboratory data with epidemiologic data.; 
	 Advance national-level incentives to ensure that commercial vendors have a return on 
investment for implementing systems that share standard laboratory information; and 
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	 Explore the utility of legal mandates for laboratory reporting to public health epidemiology 
programs. 
Objectives: 
26. Identify and leverage best practices to enable laboratory data exchange with public 
health epidemiology programs. 
27. Leverage the work of large private laboratories and establish information exchange 
between them and local public health programs.  
Goal C. Create a Governance Structure for Electronic Laboratory Information 
Exchange 
Coordinated planning and application of standards are necessary for a system that can share 
laboratory information successfully across jurisdictions, disciplines, and domains related to 
human health (veterinary, environmental, food, and agricultural). A governance structure 
implemented as part of the NHIN or other national initiatives should be leveraged to support 
Electronic Health Information Exchange and Electronic Laboratory Information Exchange.  A 
governance structure administered at the national level will:  
	 Advance the consistent application of data standards for the exchange of lab information; 
	 Ensure that guidance vehicles include specific language to promote data standards (i.e., 
PHIN and NHIN standards); 
	 Determine priorities of goals to progressively and iteratively advance electronic exchange of 
laboratory information; 
	 Assure that state and local public health organizations are key stakeholders in this effort; 
	 Assure outreach to the clinical community to harmonize clinical and public health 
information needs; 
	 Advise on priorities; 
	 Leverage ongoing national efforts to address this topic (e.g., ICLN); and  
	 Support resolution of data stewardship agreements (when data should be shared; who can 
share data; what types of data can be shared; data use and re-release parameters; what data 
protections are sufficient; legal, statutory, and intellectual property considerations). 
Objectives: 
28. Coordinate planning and advance implementation of data standards. 
29. Ensure data stewardship practices are in place. 
Goal D. Ensure Interoperability and Collaboration Across Human Health-Relevant 
Laboratory Domains 
Effective public health surveillance requires broad coordination across veterinary, 
environmental, food, and agricultural laboratory domains. Requirements will need to be defined 
to characterize the business needs and scope of data sharing among the different domains. 
Among other efforts, this goal includes close coordination with entities such as the ICLN, which 
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was formed by the Homeland Security Council and chaired by DHS to strengthen homeland 
security through a coordinated operational infrastructure of the national laboratory networks that 
encompass these domains. ICLN is working on several major initiatives to support 
interoperability: 
	 Development of a Standard Operating Procedure (SOP) for incident response across 
participating federal networks. 
	 Development of an Integrated Response Network (IRN). 
	 Development of a Data Exchange Architecture to support laboratory information 
sharing from federal networks with the National Biosurveillance Integration Center 
(NBIC). 
These initiatives may not encompass the full spectrum of laboratories and tests needed for 
biosurveillance. Additional initiatives may be required for clinical laboratories to complete the 
electronic laboratory exchange. 
Objectives: 
30. Develop a model to provide guidance to both public health and clinical laboratories on 
consistent representation of key data concepts such as sample, test, result, patient, and 
public health case. 
31. Provide guidance and best practices on the implementation of laboratory data 
standards. 
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Unstructured Data 
Surveillance data have long been collected using a wide range of media (paper, voice, electronic) 
with much of it available in free-form text or unstructured formats that can be easily interpreted 
by a person but not by a computer. Unstructured data are pieces of information such as text 
strings that are not organized or integrated for direct entry into a database. The content is often 
qualitative rather than quantitative (e.g., a narrative description of a patient complaint). As 
technology has progressed and as more information is recorded onto digital media, access to a 
broader array of information is opening up across all levels of public health, healthcare, in the 
private sector and in open sources available through the Internet making it possible to 
supplement and build a more comprehensive picture of situation awareness.  
Critical health information can be found in free-form text and other unstructured data in storage 
locations throughout public health and healthcare organizations. In a large complex public health 
agency, several workers may each know a different part of the story about an important health 
event, yet each alone does not realize the significance of the event. Key pieces of information 
that would provide context for a case report (such as the name of a restaurant) may lie in an 
epidemiology investigator’s case notes, emails  sharing information about consultations or 
investigations, consumer complaint logs, surveillance system reports, or media that are not yet 
readily searchable or computer-synthesized. Similarly valuable information may reside in 
emergency department triage nurse notes or free-text chief complaints, or in the narrative 
portions of electronic medical records or poison control center data systems.  Valuable
information contained in unstructured data is not limited to infectious disease threats, but also 
include environmental data, such as chemical or radiological exposures and patient outcomes. 
Unstructured data found in the private 
sector and in web-based sources can be 
used to augment public health and 
healthcare information. No matter how 
well the official reporting systems work, 
gaps in coverage and information still 
remain. Private health professionals may 
only see a single enigmatic case and not 
realize that other similar cases are 
presenting elsewhere in the healthcare 
system or the world. Recognizing this, 
sources such as the Public Health 
Agency of Canada’s Global Public 
Health Intelligence Network (GPHIN) 
that continuously scrutinize global news 
media sources and health and science websites give healthcare professionals additional insights 
into what is happening in the environs around them.  Similarly, Project Argus, developed and 
based at Georgetown University, is a biosurveillance system initiated in 2004. Argus was 
designed to detect and track biological events that may threaten human, animal, and plant health 
globally and in the United States by monitoring various types of social disruption evident in 
local, native-language media reports around the world. These reports range from traditional print 
and electronic media to internet based newsletters, in approximately 40 languages on every 
A citizen reports cloudy tap water to an 
environmental health worker. The worker 
enters the call notes directly into a searchable 
multi-user database, indicating the location, 
age range, zip code and general type of call as 
well as free-text narrative. At the same time, 
an epidemiologist located in a different office 
receives a call from an urgent care doctor 
describing an increase in clinic visits for gastro­
intestinal illness in the past 24 hours. When the 
epidemiologist searches the database, the 
report of cloudy drinking water pops up from 
the zip code next to that of the urgent care 
center. A joint environmental-epidemiological 
investigation of a possible waterborne outbreak 
is launched. 
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continent, except Antarctica. Over 40 federal, state and local governmental entities use Argus on 
a daily basis. 
More novel data streams, such as the number of searches for particular concepts on popular 
search engine sites, need to be further explored. Social networking technologies and web-based 
discussion forums, listservs, and blogs also have the potential to be mined for timely information 
about illness or health concerns. 
All these sources provide potentially valuable 
information that if integrated with traditional 
surveillance data and shared more widely may 
aid earlier detection of public health threats. 
However, rigorous research, applied experience, 
and shared learning are needed to develop this 
capability, and additional technologies, tools, 
and skilled analysts are needed. Also, at all 
levels, public health entities will have to 
understand and weigh the benefits and 
limitations to investing in or utilizing 
unstructured data. Data and text-mining or 
knowledge discovery tools are needed to mine 
and convert the data into computer 
understandable format. Additional technologies 
are needed to facilitate analysis and integration 
and to detect patterns and associations. For example, free-text chief complaints in emergency 
department visit records are grouped into categories with software that looks for key word 
combinations indicating the presence of a syndrome such as gastroenteritis or rash with fever. 
These techniques have also been applied to emergency department triage nurse notes and could 
in principle be applied to other free-text data in electronic health records.  
Best practices and lessons learned from federal and international systems can also help determine 
the tools and approaches that should be considered. In the United States, systems such as 
BioSense, the National Biosurveillance Integration System (NBIS), the USDA’s Veterinary 
Services system for animal health, and the Office of the National Director of Intelligence already
incorporate unstructured data into their analyses.  Global activities include systems such as 
HealthMap, Epispider, MediSys, and BioCaster.  These systems allow uptake of unstructured 
information to enhance disease surveillance activities.
While increased access to additional information is important for biosurveillance, so too is the 
professional judgment and skill, informed by proper local context, to validate and provide 
context to unstructured data analysis. For example, ProMED, a moderated listserv that serves as 
an early warning system covering human, animal, and plant disease, disseminates information 
from global news media, official national and international organizations, and direct reports from
subscribers, including “astute clinicians”. All reports are first vetted by a cadre of expert 
moderators providing interpretations and analyses as part of the information disseminated.  
Additionally, creative and low-burden methods of sharing and exchanging both raw and 
synthesized unstructured information are needed for health professionals. For healthcare and 
A state-level epidemiologist receives a 
message with a request for information 
about testing for meningococcal disease. 
Before returning the call, the 
epidemiologist searches the database for 
records with similar characteristics. One 
state health department worker and two 
county health department staffers have 
recently handled consultations about three 
different people with suspected 
meningococcal disease in the same 
metropolitan area; none of them have 
talked with the others. The epidemiologist 
convenes a quick conference call and 
organizes a joint outbreak investigation
and response. She also posts a health alert 
network item asking for additional case 
reports. 
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public health professionals, knowledge management tools and methods need to be explored to 
assist with managing information overload. 
The value of access to and utilization of unstructured data will increase exponentially as the 
number of active participants using it increases. The information available will also increase with
increased automation, integration and exchange across the healthcare environment and as more 
people are linked into these networks.  The value will be best demonstrated as more and more 
public health professionals contribute to it, use it, and evaluate its usefulness. 
Key goals that are intended to be addressed in order for this priority area include:   
Goal A. Define and Evaluate Options for the Use and Management of 
Unstructured Data 
The desired and feasible functionality of unstructured data systems needs to be clearly identified 
at all levels. An exploratory data source evaluation will then be needed to understand: the ability 
of various unstructured data (in public health agencies, medical records, and outside sources) to 
contribute to the earlier detection and assessment of threats; the level of precision supported by 
the data; and availability and cost.  
Objectives: 
32. Determine appropriate technology tools to automate the collection, analysis, and
visualization of unstructured data. Complete an inventory of methods and tools already 
in place across the nation. 
33. Determine how, where, and what unstructured data would enhance situation 
awareness. 
34. Determine what human resources will be needed to validate and analyze data for final 
analysis. 
35. Determine what functions can and should be supported. 
Goal B. Develop the Capacity to Collect and Utilize Unstructured Data for 
Biosurveillance for Human Health Purposes 
Intelligence and business communities both have well-developed tools and techniques for 
aggregating, analyzing, and using unstructured data and information. Health professionals can 
learn from these experiences and move ahead to obtain data, analyze them, and display 
information to assist decision making. As the use of unstructured data is not widespread across 
public health, active collaborations and sharing of best practices help accelerate progress in this 
area. 
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Objectives: 
36. Evaluate options for capturing information from existing and available sources in 
public health and healthcare. 
37. Develop a public health ontology to be used in collecting web-based unstructured data. 
38. Develop pilot systems that collect, manage, and support analysis of unstructured data as 
part of biosurveillance.
39. Evaluate effectiveness of various types of unstructured data in achieving the purposes 
of biosurveillance. 
Goal C. Promote Implementation and Use of Information Products and 
Technologies that Utilize Unstructured Data Most Effectively
Partnerships among federal, state, and international entities are necessary to achieve effective use 
of unstructured data. To achieve maximum impact, technologies for using unstructured data to 
enhance surveillance must be made widely available and must have the ability to collect data 
from a great variety of sources. For systems that depend on harvesting data already in public 
health agencies, there will be costs associated with assuring that data are captured electronically 
and made available to the surveillance engine that will be looking for patterns and anomalies. 
Training will also be needed in order to gain the best advantage from these systems. Systems that 
harvest and analyze data from publicly accessible sources (e.g., through the Internet) will need to 
be implemented nationally but will still require local- and state-level support and training in their 
use to be fully effective. Ongoing assessment of usefulness needs to be included in 
implementation plans so that science-based guidance can be shared to improve the utility of these 
data. 
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Integrated Biosurveillance Information
A critical function of biosurveillance is the ability to rapidly, reliably, and securely collect, 
synthesize, and share diverse biosurveillance information among public health, healthcare and 
other response entities. Integrated biosurveillance information can provide a more 
comprehensive picture of the health status of the nation’s communities in order to enhance 
decision making. Because the responsibility for public health is shared across multiple levels of 
government, professional practice, and scientific disciplines, the timely exchange of reliable and 
actionable information is essential.  
Public health leaders share a long history of working together to identify, prevent, monitor, and 
respond to health events. The need for a biosurveillance capability to support data integration, 
communication networking, and situation awareness has become more acute with globalization 
and the increasing availability and complexity of health-related information. Advances in 
technology and epidemiologic science hold the potential to support communication networks that 
lead to earlier awareness of hazards and events, real-time monitoring as events unfold,
connectivity to the evidence, and greater access to knowledgeable public health and healthcare 
professionals. However, greater access to electronic health-related information comes with the 
responsibility to continuously evaluate what data and information are cost-effective and 
actionable. Integration occurs at all levels, from the local to international, and requires human 
interpretation and decisions at every stage. Enhancing the effort to integrate biosurveillance 
information is a dual challenge of creating networks to deliver data to people and simultaneously 
supporting networks of people to turn the data into actionable knowledge.  
Situation awareness tools that support integrated biosurveillance are as simple as a telephone call 
between different sectors and as complex as common operating pictures that produce automated 
dashboards or visualization tools of community health hazards and public health events. 
Activities are needed to determine how to best use and build upon information sharing 
innovations. It is important to have a clear definition of requirements: what decisions are needed, 
what data may be needed, what data are not needed, what data are needed for, how data are to be 
collected, and what products need to be produced. This is critical for:
 Information integration and sharing at the state, local and tribal level 
 Information integration and sharing at the federal level 
 Information integration and sharing with the private sector
 Information integration and sharing with international partners 
Key goals for this priority area include:   
Goal A. Define Requirements for Multi-Level Situation Awareness Monitoring and 
Reporting 
The critical information requirements for public health situation awareness must necessarily cast
a wide net and be flexible, increasing in detail as an event unfolds. Requirements must provide 
for 1) identifying public health events or threats of all types worldwide; 2) monitoring potentially 
impacted jurisdictions when events that may be imminent; 3) estimating threat impacts to staff
and resources; and 4) communicating newsworthy public health events, with appropriate 
qualification of validity.
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Multiple types of information products for different types of clinical and public health decision 
makers will be needed. For example, stakeholders report a need for a common operating picture 
for human health accessible through Internet-based capabilities (e.g., dashboards and GIS maps) 
and offering varying stakeholder access rights to support differing levels of decision making. The
common operating picture would be enhanced through human review and analysis coupled with 
computational tools capable of automated event detection through integration and analysis of 
multiple streams of information. This picture should offer a unique lens on human health that 
supplements and is augmented by other information sources. Further discussions are needed to 
understand and provide for this specific requirement.  
Objectives: 
40. Assess existing approaches, tools, and techniques for biosurveillance information 
integration. 
41. Define requirements necessary for situation awareness and bi-directional exchange of 
information at the local, state, federal, and international levels as well as between 
government and private sector. 
42. Complete an inventory of existing sources of information, methods, and techniques and 
evaluate these for their effectiveness and appropriateness for a nationwide situation 
awareness capability.
43. Develop protocols for the integration of unstructured and other biosurveillance data to 
inform decisions before, during, and after significant health events.  
Goal B. Establish a Nationwide Capability for Integrated Biosurveillance 
Information Management and Exchange 
Frameworks for expanded information sharing and data integration, guidelines, policies, and 
standard operating procedures are needed to guide public health, healthcare, and private sector
stakeholders as they work together to analyze, interpret, and respond to information. Alignment 
with supporting frameworks for preparedness and response will be important in ensuring roles 
and responsibilities are understood and respected. 
Objectives: 
44. Establish governance for federal programs for human health information standards 
and integration. 
45. Articulate technical requirements for integration and key system improvements needed 
for existing health-related biosurveillance systems to ensure the usability of those 
systems for integration.
46. Leverage existing databases, systems, and networks available across federal agencies. 
47. Develop the tools and infrastructure necessary for integration.
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Goal C. Create a Collaborative Environment for Sharing of Situation Awareness 
Information and Health Intelligence  
Activities associated with this goal will reduce barriers to communications and create a 
collaborative environment for situation awareness dialogues and knowledge exchanges among 
multi-disciplinary experts and representatives of stakeholder groups. Biosurveillance information 
products will include complete and consistent guidance to direct prevention and control actions 
and will be developed with and distributed among state and local public health departments as 
trusted agents. Achieving improved situation awareness will only work with support from
stakeholders. Memoranda of agreement (MOAs) or understanding (MOUs) are means by which 
to establish a clear delineation of working relations between organizations. These agreements are 
needed to ensure that a trusted environment for open and transparent discussions is established 
where preliminary and incomplete information can be posted without the need for stringent 
levels of clearance or editing. 
Active outreach opportunities will be pursued to ensure that the private sector is also represented, 
meeting the needs of their constituents and identifying ways that they and their organizations can 
participate in biosurveillance efforts. Similarly, expanded communications—along with greater 
coordination and cooperation—will take place among the larger scientific, government 
intelligence, and industrial sectors (e.g. Epi-X). These synergies will prove vital in advancing 
basic knowledge of biosurveillance, in creating new approaches to early detection, in creating 
new technologies to improve environmental surveillance, and in fostering a shared responsibility 
for protecting the nation’s health. 
Objectives: 
48. Establish MOUs with agencies and stakeholders for participation and information 
sharing. 
49. Develop multi-disciplinary communities of practice to foster learning and knowledge 
exchange. 
50. Develop the policies, tools, and incentives necessary to collaborate and share knowledge 
and expertise. 
51. Promote linkages and partnerships with other international, federal and state 
information-sharing processes and initiatives as appropriate. 
52. Create a mechanism to provide nationally generated analyses and threat assessments to 
state, territorial, tribal, and local health authorities in a timely fashion. 
Goal D. Provide Technical Assistance and Support State and Local Health 
Departments to Integrate Biosurveillance Information Products and 
Processes 
To achieve maximum impact, integration technologies, situation awareness information 
products, collaboration practices, and standards must be made widely available at all levels of 
public health and healthcare. States and local public health organizations must develop scientific 
agendas and programs to determine how these new tools will become part of routine public 
health practice. Where value can be demonstrated, state and local stakeholders must have the 
resources to implement these capabilities.
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Global Disease Detection and Collaboration 
The 2007 World Health Report notes that “the world is at increasing risk of disease outbreaks, 
epidemics, industrial accidents, natural disasters and other health emergencies which can rapidly 
become threats to global public health security.”16 The report recognizes that “since the 1970’s, 
newly emerging diseases have been identified at the unprecedented rate of one or more per year.”
The 2008 document World at Risk: Report of the Commission on the Prevention of WMD 
Proliferation and Terrorism states “unless the world community acts decisively…it is more 
likely than not that a weapon of mass destruction (with high probability it will be a biological 
weapon) will be used in a terrorist attack somewhere in the world by the end of 2013.” 17 
Infectious diseases such as Ebola hemorrhagic fever, AIDS, and SARS are all recent arrivals on 
the world stage. The Institute of Medicine’s 2003 report Microbial Threats to Health 
recommends actions necessary to meet these global health challenges. The report stresses that the 
United States should seek to enhance the global capacity for responding to infectious disease 
threats, and it should take a leadership role in promoting the implementation of a comprehensive 
system of surveillance for infectious diseases wherever they arise.
At the same time, advancements in transportation, communications, and manufacturing have 
made us an interconnected society, a global village, where events that impact one part of the 
world can spread rapidly to affect other regions. For example, in September 2008, melamine 
contaminated infant formula and related dairy products originating in China were found in 
locations world-wide.18  The breadth of potential global public health threats is recognized in the 
provisions of the revised International Health Regulations [IHR (2005)] with its all-hazards 
approach to assessing serious public health threats. These regulations are designed to prevent and 
protect against the international spread of diseases while minimizing interference with world 
travel and trade. They prompt countries to work together to share information about known 
diseases and public health events of international concern. 
Visibility of emerging health threats around the world is contingent on the local capability to 
detect and investigate those threats and on a continued connection to the international health 
workforce. Clinical surveillance of disease is inadequate in much of the developing world due to 
limited funding for public health infrastructure. Attention needs to be focused on improving 
response and detection capabilities in the developing world where infectious diseases are most 
prevalent and opportunities for spread are considerable.  
A major challenge to global disease surveillance and detection is to not only detect and report 
well-characterized known infectious diseases, but also to detect novel, emerging, or reemerging 
diseases in relatively low-tech environments. There is a corresponding need to develop 
redundant and complementary systems for infectious disease detection that go beyond the yield 
of traditional surveillance systems and approaches. 
16 World Health Organization, The World Health Report 2007: A Safer Future:  Global Public Health Security in
 
the 21st Century (Geneva:  WHO, 2007):10. 

17 World At Risk: The Report of the Commission on the Prevention of WMD Proliferation and Terrorism, December 

2008. 

18 FDA Updates Health Information Advisory on Melamine Contamination, 

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01891.html. Accessed October 21, 2008; Melamine-

contamination event, China, September - October 2008,
 
http://www.who.int/foodsafety/fs_management/infosan_events/en/index.html. Accessed March 5, 2010. 
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The vision for global surveillance and collaboration is to have global surveillance capacity at 
home and abroad working collaboratively with WHO and other international partners to 
recognize, communicate, and respond to public health events of international concern. Actions to 
realize this vision include leveraging existing global surveillance systems, enhancing and 
building global surveillance and response capabilities at home and abroad, and strengthening 
partnerships between the United States and the international health community.  Since many 
efforts exist across the federal sector, coordination is needed.  The Executive Office of the 
President (EOP), along with a designated lead federal agency, should coordinate U.S. 
government policy and programs on global biosurveillance.  The lead agency should improve 
communication across U.S. federal entities and should craft, coordinate, and implement 
multilateral initiatives that strengthen core capabilities in global biosurveillance and respond to 
public health emergencies as outlined in the revised IHR.   
Key goals for this priority area include: 
Goal A. Strengthen Partnerships and Leverage Resources of U.S. Government 
(USG) and Non-USG Partners 
An integrated and coordinated global biosurveillance network is critical in achieving and 
containing emerging health threats. USG agencies will work with their partners to integrate 
activities and create synergies across existing programs and communications networks. These 
network partnerships include those associated with WHO and programs such as CDC’s Global 
Disease Detection (GDD) program, the Early Warning Infectious Disease Surveillance program
(EWIDS), the National Biosurveillance Integration System (NBIS), the Global Public Health 
Information Network (GPHIN), DoD’s Global Emerging Infectious Surveillance and Response 
System (GEIS), the Program for Monitoring Emerging Diseases (ProMED-mail), Global 
Outbreak Alert and Response Network (GOARN), and others. 
Objectives: 
53. Develop a strategic plan to strengthen partnerships between WHO, USG agencies, and 
non-USG partners in global disease detection efforts. Include collaboration across USG 
initiatives to leverage existing in-country programs and build links between them. 
54. Collaborate with WHO to define responsibilities and integrate initiatives across WHO 
and USG agencies to strengthen core capacities in global disease detection and response 
efforts.  
55. Explore additional partnerships with non-USG partners for furthering global disease 
detection activities. 
56. Strengthen partnerships with non-risk/lower-risk countries that have strong resources 
for global surveillance and response (e.g., European Union member states, Canada, and 
Japan). 
Goal B. Adopt a Risk-Based Approach to Focus Efforts in Areas of Greatest 
Vulnerability, Need, and Impact
Adoption of a strategic risk-based approach will help to anticipate vulnerabilities and to detect 
and control the global spread of disease. A renewed effort focusing on geographic hotspots is 
needed because they have high population density or because they experience recurring 
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infectious disease outbreaks (e.g., Ebola outbreaks in Uganda, Kenya, and the Democratic 
Republic of Congo; or chikungunya, Nipah, and influenza outbreaks in Southeast Asia). A focus 
on the highest priority threats will ensure more rapid identification and response to a wide range 
of emerging infections, including respiratory syndromes, diarrheal diseases, food borne illnesses, 
and zoonotic diseases, through integrated disease surveillance, prevention, and control activities. 
Objectives: 
57. Form a steering committee with infectious disease and other subject matter experts to 
assess and update the top priority threats or pathogens of global concern. 
58. Develop and routinely update the top priority threats or pathogens to which 
biosurveillance capabilities should be directed on a global scale.  
59. Identify the key regions of the world (e.g., regions with significant potential for 
emerging infectious diseases but with limited local capacity for detection and control) 
on which to concentrate global biosurveillance efforts.  
60. Establish a standardized process for allocation of global biosurveillance resources. The 
process would use criteria such as record of past collaboration, ability of local 
government to ensure personnel safety, population density of region, availability of 
local resources, and history of emerging threats to assist in decision-making.  
 Goal C. Build In-Country Public Health Facilities and Expertise in support of IHR 

2005 

Biosurveillance activities need to focus on building in-country capacity, especially in areas with 
limited local resources and/or infrastructure to support rapid disease detection and effective 
response activities. This includes ensuring appropriate containment facilities, equipment, 
policies/practices, security precautions, and occupational health programs to encourage working 
safely with highly pathogenic agents, and strengthening laboratory operations by standardizing 
test procedures, laboratory protocols, and management practices.  
International workforce development, laboratory and epidemiology capabilities have been a 
cornerstone of U.S. foreign assistance and facilitate awareness of health threats and of the U.S. 
role as trusted consultants in the prevention and control of health emergencies in the international 
community. In addition, investments in disease detection and capacity development support the 
implementation of the revised International Health Regulations (IHR 2005). 
Objectives: 
61. Strengthen international partnerships and educational programs that build 
surveillance and laboratory capability and capacity.
62. Strengthen partnerships with non-risk/lower-risk countries (e.g., European Union 
member states, Canada, and Japan) that have strong capacity building resources for 
global surveillance and response.
Goal D. Support Efforts to Connect the Worldwide "Network of Networks" to 
Foster More Rapid Information Sharing and Earlier Detection 
Although many developed countries are strengthening their surveillance systems and capacities, 
the required health information infrastructure is lacking in parts of the world that may be most 
vulnerable to emerging health threats. The existing network of surveillance by health ministries, 
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institutes of public health, multinational agencies, and laboratory and institutional networks has 
gaps in geographic coverage and often suffers from poor information flow across national 
borders. In addition, focused efforts are needed in health risk communication and technology to 
strengthen communication with affected populations during outbreaks and to assure that public 
health responses are culturally, technologically, and scientifically appropriate and disseminated 
in the most cost-effective, time-sensitive manner possible.
Objectives: 
63. Develop regional mutual assistance arrangements for information and health alert 
resource sharing through interoperable electronic networks/systems to improve timely 
reporting for public health emergencies of international concern in support of the 
World Health Organization’s 2005 revised International Health Regulations. 
64. Determine requirements for field technologies that support situation awareness and 
real-time data analysis across international borders.
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Biosurveillance Workforce of the Future 
Championing the importance of the human element in biosurveillance is critical to the success of
The Strategy. Maintaining current capabilities and meeting future challenges will require an 
extensive, well-trained, and strongly motivated workforce. Building capacity will require vision, 
commitment of resources, and creative solutions to extend the skills of the workforce.  
The critical functions of public health surveillance and investigation of exposures and acute 
human health events are widely distributed across local, state, federal and international 
jurisdictions. Professionals from diverse disciplines provide the range of skills necessary for 
biosurveillance to work effectively. As we transition from biosurveillance today to 
biosurveillance of the 21st century, the nation will continue to need people trained in fields that 
traditionally have been associated with surveillance and investigation, such as in epidemiology, 
laboratory sciences, and environmental health.  In the healthcare sector, astute clinicians, e.g., 
infection preventionists - formerly known as infection control professionals - remain a critical 
link in biosurveillance. 
Professionals in other disciplines, such as pharmacists and medical examiners, play an
increasingly important role as well. Animal and plant health experts, veterinarians, plant 
pathologists, and agricultural specialists also contribute to biosurveillance given their expertise in
zoonotic and environmental-associated health events. The legal, justice, and security realms are 
important partners that are collaborating more closely with public health, especially since 9/11. 
Their participation has been apparent during recent pandemic influenza response planning efforts 
and will continue to be integral to biosurveillance. Specialized skills are needed to perform and 
support data analysis, statistical modeling and information fusion to achieve health intelligence.  
In addition, professionals are also needed from other diverse fields including physical, chemical, 
radiological, mathematical, informatics, and computational sciences. As we move forward, 
interdisciplinary knowledge and specialized expertise will be critical to assimilating traditional 
information sources with new systems and methods for collecting and analyzing health 
information. 
The vision for the biosurveillance workforce needs to articulate both what the responsibilities 
will be for primary public health professionals (epidemiologists, laboratorians, environmental 
health specialists, and informaticians) and how to engage and coordinate frontline clinicians 
(physicians, veterinarians, nurses, and others) and the various other stakeholders involved. 
Innovative strategies that include working with health departments and schools of public health 
must be applied to recruit and retain workers from diverse fields. Cross-training of personnel 
should aid in incorporating new technologies into public health practice. New curricula are 
needed, and should be applied through proven and new public health fellowship programs, 
training centers, and mentorship opportunities to produce the next generation of public health 
professionals. Simultaneously, similar needs must be met for healthcare professionals and the 
range of other disciplines participating in biosurveillance. Comprehensive and systematic efforts 
to enhance workforce capability ideally would result in cohesive networks of competent 
professionals responsible for biosurveillance functions. 
Significant gains in biosurveillance workforce capacity have been achieved at the state and local 
level since 2002. Public health emergency preparedness funding has enabled the establishment 
of trained epidemiologists, laboratorians, and other public health professionals.  These efforts 
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have not addressed the issues of an older public health workforce, nor the cross-training of 
individuals in other disciplines. Combined with waning federal funding and strapped state 
budgets, the progress that has been made is threatened and additional critical progress is delayed.  
Workforce capacity must be maintained while a human capital strategy is developed as part of an 
integrated National Biosurveillance Enterprise.  
A clearly delineated human capital strategy is needed to articulate an integrated workforce 
approach that views the many participants as a pool of talent to be configured and developed 
strategically to create the most public benefit. The coordinated governance structure will engage
multidisciplinary stakeholders to facilitate planning and establishing workforce standards and 
competency levels across all jurisdictions and disciplines.  Strengthened inter-sector 
collaboration is needed to leverage public health, healthcare, academia, the private sector and 
others to better articulate roles, determine appropriate training needs, and guide professional 
standards, policies, and funding to build the necessary human infrastructure.   
A human capital strategy will provide an overarching framework for defining what is needed and 
for managing the multiple stakeholders and entities involved. This human capital strategy will 
need to address several pressing challenges including:  
	 The magnitude of the human capital investment in biosurveillance.  To ensure a 
continuously strong biosurveillance workforce at the local, state and federal levels, an 
assessment is needed of the current workforce and the assets invested to achieve the current 
level of biosurveillance. The assessment must include those in public health agencies with 
the legal authority to conduct surveillance and investigate possible warning signals, as well 
as those in healthcare organizations and other key stakeholders.  Doing so will enable a 
determination of what ongoing human capital infrastructural investment will be needed to 
maintain and enhance the workforce to meet the vision of the future. 
	 Frameworks for continuous learning and training. A broadened training and education 
framework is needed to ensure current and future workers are prepared to meet the 
challenges ahead. Such a system would articulate professional roles and competencies 
necessary for biosurveillance and offer training and career-development paths. Doing so in 
an efficient manner is a step toward ensuring availability of needed workers and job 
opportunities, training, and viable career paths for health professionals at the local, state, 
national and global levels. 
	 Recruitment and retention of professionals. Serious public health and healthcare 
workforce shortages already exist. States and communities nationwide report needing more 
public health nurses, epidemiologists, laboratory workers, informaticians, statisticians, and 
environmental health experts. The Association of Schools of Public Health (ASPH) estimates 
that 250,000 more public health workers will be needed by 2020 just to maintain current 
capacity.19 Innovative strategies are needed to address the underlying factors behind the 
19 ASPH 2007 State Public Health Survey Results, and 2004 and 2006 surveys by the Association of State and
Territorial Health Officials
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shortfalls, such as the exodus of retiring workers, an insufficient supply of trained workers, 
inadequate funding, and uncompetitive salaries and benefits.20 
	 Access to specialists. Professionals performing biosurveillance need access to specialists 
such as statisticians, epidemiologic and mathematical modelers, information and decision 
scientists, informaticians, natural language processing experts, analytic data management 
programmers, knowledge managers, and disease and GIS mapping experts. Insufficient 
numbers and competency in biosurveillance exist in these groups at a time when demands on 
the health system are increasing.
Key goals for this priority area include:   
Goal A. Assess Current Biosurveillance Workforce Capability, Identify Gaps and 
Articulate Needs 
Creating a stronger biosurveillance workforce begins with a solid assessment of workforce 
requirements and the interrelationships between local, state, federal, and other stakeholder 
agencies. Next comes an assessment of reliable and available workforce data and a keen 
awareness of trends at the local and national levels that have an impact on the workforce pool, 
affect the workforce’s strengths and weaknesses, and influence the skills and resources needed. 
The assessment must recognize how biosurveillance events are typically detected and 
communicated. This includes an emphasis around the intersection of healthcare and public 
health. It is about ensuring that the nation has and will continue to have the right people with the 
right skills in the right job at the right time performing their assignments efficiently and 
effectively. Activities will leverage existing resources to create multi-level baselines and an 
integrated human capital workplan that will meet the following objectives: 
Objectives: 
65. Define which biosurveillance workforce requirements and strategies (laboratory and 
electronic systems) are essential at each level of the public health system. 
66. Catalog current human capital and technological investment in biosurveillance and 
initiatives to plan for the future biosurveillance workforce at the state, territorial, tribal
and local levels.
67. Characterize and model staffing requirements in the current workforce across public 
health and healthcare; assess further need and future supply. 
68. Develop a human capital plan as part of an integrated National Biosurveillance 
Enterprise.
69. Maintain local and state biosurveillance workforce until objectives and funding needs 
for the National Biosurveillance Enterprise have been defined.
20 Public Health Workforce Shortages Imperil Nation’s Health, Center for Studying Health System Change, 
Research Brief, No. 4, Apr 2008. 
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Goal B. Ensure a Competent Biosurveillance Workforce 
A national training and education framework is needed to articulate professional roles and 
competencies necessary for the biosurveillance workforce, and to offer guidance on training 
needs as well as career-development paths. Competency frameworks defining the necessary 
skills and skill levels, such as one developed by CDC and CSTE for government public health 
epidemiologists, offer guidance for state and local education planning. Development of curricula 
based on competency models would expand into new areas important to biosurveillance 
including informatics, genomics, cultural competence, community-based participatory research, 
global health, and ethics. Entry level, continuing, and advanced training curricula must be 
provided for the biosurveillance workforce. Collaborations among public health, healthcare, 
academia, and the private sector must be strengthened to leverage resources, guide professional 
standards, and develop educational policies for continuing education and academic curricula.  
Objectives: 
70. Develop competency models for key biosurveillance roles both for routine public health 
operations and adequate surge capacity, leveraging existing work when applicable.  
71. Develop curricula based on competency models.
72. Expand proven educational programs such as fellowships and training networks.  
73. Identify opportunities for cross-disciplinary training and education. 
74. Identify opportunities and strategies for entry level, continuing, and advanced level 
education. 
75. Enhance the capability within partner organizations and associations to influence 
professional standards and provide training and education. 
76. Establish career tracks for interagency service and National Biosurveillance 
Information System (NBIS) participation among federal agencies that are part of the 
NBIS. 
Goal C. Develop Competitive Strategies to Recruit and Retain an Effective 
Biosurveillance Workforce 
Effective biosurveillance requires more than training; building workforce capacity through better 
recruitment and retention strategies is also needed. The capacity-building function of the federal 
government will be crucial to ensuring that state and local levels of government have the 
resources—human, financial, and organizational—needed to carry out the responsibilities 
delegated to them by the federal government or for which they are responsible by law. New 
policies and incentives must also be created to make careers in public health, and especially 
those related to biosurveillance, an attractive professional path, particularly for the emerging 
workforce and for those changing careers. At the national level, the biosurveillance enterprise
should include efforts to recruit, hire, and retain competent, trained personnel involved in 
planning, evaluation, designing, and executing biosurveillance programs at local, state, and 
federal levels. 
The nation—and the world—will continue to need people trained in health fields, such as in 
epidemiology, laboratory sciences, biostatistics, environmental health, that traditionally have 
been associated with surveillance and investigation. In addition to addressing shortfalls in critical 
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biosurveillance positions, however, there is a need to recruit people from other diverse fields 
including physical, chemical, mathematical, informatics and computational sciences (to apply 
their expertise to biological questions); ecology and evolutionary biology (to help with an 
understanding of the human–microbe interface); and the plant and veterinary sciences (to help in 
understanding the flow of diseases between humans, animals, and plants). 
Objectives: 
77. Develop model position descriptions (based on competencies) and job classifications, 
where lacking, to facilitate hiring processes.
78. Design and develop innovative recruitment strategies and related career paths for 
biosurveillance positions.  
79. Promote use of internships, fellowships, career-experience opportunities, and tuition-
for-service programs as recruitment and retention strategies.
80. Explore recruitment of technical experts to government through the use of 
Intergovermental Personnel Assignments (IPAs) and other mechanisms. 
Goal D. Establish a Governance Body for Biosurveillance Workforce 
Active and timely communication and collaboration among workers representing all public 
health jurisdictions, agencies, and healthcare communities is a key feature needed for an 
effective biosurveillance environment. A governance structure administered at the national level 
will assure consistency in workforce planning and establishment of workforce standards and 
competency levels across jurisdictions and disciplines. 
Activities will leverage governmental, public-private, and academic partnerships to build the 
necessary infrastructure and to reach and engage multi-disciplinary stakeholders. Collaborations 
among traditional public health partners (such as the Association of State and Territorial Health 
Officials, National Association of County and City Health Officials, Council of State and 
Territorial Epidemiologists, and Association of Public Health Laboratories) and other important 
professional organizations (such as the American Medical Association, National Environmental 
Health Association, and American Medical Informatics Association) must be strengthened.  
Objectives: 
81. Ensure leadership and support for nationwide biosurveillance workforce initiatives. 
82. Establish regional and cross-jurisdictional networks of biosurveillance professionals in public 
health and healthcare. 
83. Strengthen academic partnerships and establish biosurveillance-related centers of
excellence.
84. Strengthen communication and interactions with private sector.
85. Strengthen organizational capacity of key partners working in support of competency 
development, training, and biosurveillance workforce initiatives.  
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The Way Forward 
The Strategy provides the foundation for a long-term effort to improve nationwide capability to 
manage health-related data and information for early warning of threats and hazards, early 
detection of adverse human health events, and overall situation awareness so that effective 
actions can be undertaken to mitigate health effects. It is important in this effort to first recognize 
the current nationwide capability and then to build upon it.  
Active Outreach and Continued Development 
Within the federal government, HHS and CDC will continue to play an active coordinating role 
in developing and implementing The Strategy. In addition to executing its specifically assigned 
responsibilities and initiatives, CDC will serve as the primary federal point-of-contact for state 
and local governments, the private sector, and the American people on issues related to 
biosurveillance for human health.  
In accordance with that role, CDC will disseminate The Strategy widely, at the same time 
seeking additional updated input from stakeholders across the nation who contribute to and will 
benefit from the products of biosurveillance for human health. The Strategy will continue to be 
maintained in a manner that reflects progress, new ideas, increased knowledge, and changes in 
the healthcare industry and the related political environment. In this way, it is intended that The 
Strategy will be a catalyst for the unification and integration of the work of all concerned 
stakeholders. 
Planning activities will continue to reflect an emphasis on partnering closely with stakeholders, 
tapping into their knowledge, experience, and information requirements, and adapting 
information products that will be supportive of them in their daily activities, as well as in 
preparedness planning. It is hoped that such an open and transparent approach toward strategy 
development will build confidence in the nation’s biosurveillance capability and its management. 
Nationwide dialogue will also be encouraged to reach agreement on those critical issues for 
which there is not yet consensus. 
In support of collaboration and further development, the activities cited below, among other 
coordination activities, will occur:
	 Biosurveillance for Human Health Work Groups will continue to collaborate on issues of 
critical interest in the field of biosurveillance and on refining The Strategy, its principles, 
priority areas, and goals. 
	 The Work Groups and other partners will also begin to focus on key elements of The 
Strategy’s Concept Plan for Implementation of the National Biosurveillance Strategy for 
Human Health (Concept Plan), including identifying a governance model for 
collaboration (see details below), compiling a comprehensive Registry of existing 
biosurveillance activities, and on developing an approach to communicating the efforts of 
this biosurveillance enterprise more widely.
	 The National Biosurveillance Advisory Subcommittee (NBAS) will continue to provide 
guidance and recommendations that will influence The Strategy. 
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	 Recommendations made by other key organizations concerned with biosurveillance 
activities, such as the Government Accountability Office and the Institute of Medicine, 
will be incorporated into The Strategy as appropriate. 
	 Work will continue on development of a “vision” for public health surveillance, as 
follow-on to a 2009 workshop which included leading CDC scientists and analysts, along 
with key partners. The meeting addressed the topics of lexicon, global surveillance, IT, 
workforce, data sharing, and analysis, and will result in a draft vision statement. This 
activity will, in turn, help shape The Strategy’s overall approach to enhancing 
biosurveillance capability. 
	 Outreach will be undertaken to important disciplines, such as the veterinary, plant, and
environmental health communities whose involvement and input are critical to a 
comprehensive strategy. 
	 The Strategy will continue to be integrated and aligned with relevant U.S. laws and 
executive orders which address biosurveillance and other related official policies such as 
those noted in the National Health Security Strategy and the National Response 
Framework. 
	 A governance structure will be proposed to address biosurveillance challenges and 
opportunities and to provide a forum for the voicing of concerns, offering of suggestions, 
and decision-making. It will enhance relationships, increase effectiveness via joint effort, 
provide leadership, and support cohesiveness among participants. The important role of 
governance for achieving success of The Strategy’s overall goals and objectives is 
addressed below. 
Governance 
In the course of development of The Strategy, it has become evident that there is a need for the 
establishment of an overarching intergovernmental framework, (i.e., a governance “enterprise”) 
to monitor and implement progress in The Strategy’s priority areas, goals and objectives. There 
is currently no encompassing organizational structure that has an authoritative role in carrying 
out the objectives of a national biosurveillance system or in setting out a related implementation 
plan. The absence of authoritative governance has slowed progress in bringing into closer 
cooperation the many separate surveillance programs nationwide serving a variety of purposes. 
Governance is a recurring theme underlying most of the important goals and objectives of The 
Strategy. Sometimes the call for governance is explicit. More pervasively, with regard to a host 
of other objectives (to create policies and principles, ensure leadership and support, establish 
forums, engage stakeholders, coordinate planning, recommend resources, etc.), all implicitly 
require some form of organizational framework to bring them to fruition. This conclusion has 
been reinforced repeatedly in discussions with The Strategy working groups and in wide-ranging 
consultations with stakeholders at all levels. 
The NBAS report also highlights the need for a governance structure over the biosurveillance 
process as one of its most important recommendations. It calls for the Executive branch to define 
the strategic goals and priorities of federal investments in biosurveillance activities and 
technologies and for the White House to establish an Interagency Biosurveillance Coordination 
Committee to ensure implementation. “The Committee” would, in addition to setting strategic 
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goals and priorities, ensure that programs are subject to performance assessments and establish 
clear criteria to evaluate biosurveillance activities. The NBAS, in recommending that 
biosurveillance governance be elevated to a high level within the Executive branch, has touched 
on a key principle that is also implicit in The Strategy, that establishment of an empowered 
organizational oversight body is imperative to ensuring the realization of significant 
improvements in the national biosurveillance capability. 
In response to this clear call for an overarching authority over biosurveillance improvement, the
Concept Plan for the Implementation of the National Biosurveillance Strategy for Human Health 
(Concept Plan) sets out guidelines, optimum organizational traits, and a proposed model for 
governing the biosurveillance enterprise. The model structures which were reviewed and 
considered by stakeholders as noted in the Concept Plan include a non-federal entity, a federal 
interagency working group, and a federal advisory committee. The Concept Plan describes a 
preferred governance model, and because of estimates that the model may take time to 
implement due to organizational complications, it also lays out an interim model. Both the 
interim and optimum models adopt the federal advisory committee approach, and would consist 
of members representing varying levels of government and the private sector; however, the 
interim approach could be implemented more quickly. 
Two principles should be maintained as discussions proceed on what governance model will 
ultimately be selected by stakeholders and decision makers. First, preserving the principle of
collaboration and consensus among all levels of participants throughout the process is essential.. 
Second, wherever practical, the governance structure should be built upon existing surveillance 
structures rather than creating new organizations and mechanisms. The governance framework is 
intended to interact with other agencies and governance bodies in accordance with The
Strategy’s commitment to leverage existing surveillance systems and relationships when 
possible. 
While the Concept Plan presents a preferred governance model recommendation, it is anticipated 
that there may be modifications to the basic approach and that alternative proposals may also 
emerge. This is all in accordance with the objective of welcoming broad input and fresh ideas 
into the process, and encouraging buy-in on the part of all stakeholders to the ultimate 
governance model to be utilized. It is also envisioned that stakeholders will provide regular 
feedback on the effectiveness of the governance model being employed, with the ultimate goal of 
continued enhancement of nationwide biosurveillance capability.
National Biosurveillance Registry for Human Health 
The National Biosurveillance Registry for Human Health (NBRHH) is being developed as a 
means to enhance our nation’s biosurveillance capability by first assessing what assets are 
currently available. The NBRHH is a comprehensive, electronic registry of information about 
five types of surveillance-related activities:   
 Surveillance systems—electronic-based (Information Technology or IT) and paper-based  
 Registries 
 Surveillance programs  
 Collaboratives established to advance surveillance science and practice 
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 Tools that support surveillance 
The goal of the NBRHH is to provide information about currently available surveillance 
activities pertinent to human health across a number of different domains (e.g., human, animal, 
environmental, food, plant, and vector). These data will be most useful to decision makers at 
various levels of government who either engage in surveillance related activities or rely on 
timely data in response to a public health event. They will also be useful to program managers 
who are planning new systems or those who wish to partner with other programs conducting 
surveillance in the same area or using the same platform to collect surveillance data. 
Populating the NBRHH will be done on a voluntary basis by program points of contact, via an 
online survey instrument. Each point of contact for a system or program will input descriptive 
information into this survey, such as: name, affiliation, funding and performance measures. 
Actual surveillance data will not be available through this registry. The NBRHH will include 
only information about these systems and activities. It will not contain any data collected by 
them. 
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Achieving a Common Purpose
With a public health system having decentralized authorities and capabilities for early warning, 
detection, and response, leadership is needed across the biosurveillance enterprise to ensure that  
jurisdictions at all levels are protected from health threats and vulnerabilities. Through shared 
information and standards of practice and performance, a nationwide biosurveillance capability 
for human health serves as a sentinel to herald early action and the foundation of competent 
decision-making as events evolve. At the same time, state and local governmental leadership, 
supported by sufficient federal funding, can continue their responsibilities for creating and 
sustaining local capacities.  
Achieving the right balance between improving near-term biosurveillance capability and 
building for the future will require openness and consensus building. New biosurveillance 
requirements will increase the need for investments – both in building the national enterprise of
complementary systems that produces integrated health intelligence and in strengthening the 
comprehensiveness, quality, and timeliness of individual biosurveillance systems in place across 
the nation. A balancing and prioritizing of new initiatives and existing programs, with 
appropriate trade-off decisions, will be needed. Use of The Strategy’s goal framework will help 
integrate individual agency plans into a common, comprehensive, costed plan. With a common 
Strategy as a touchstone, coordinated guidance will be developed to simplify and harmonize the 
various existing and planned federal- and state-level biosurveillance activities for human health.  
The Strategy will not dictate agency policy, but will allow each agency to plan and implement 
programs to fulfill its responsibilities in biosurveillance and be accountable for its performance. 
Baseline and investment-oriented measures will evaluate the effectiveness of the activities and 
programs, allowing agencies to justify their investments, make resource allocation decisions, and 
adjust priorities accordingly.  
Through the implementation of The Strategy, the United States can fulfill the vision of 
Biosurveillance in the 21st Century. This vision will only be achieved through work performed at 
all levels of government, in healthcare, academia and the private sector. Active participation is 
required of all stakeholders and sustained leadership and action is needed at the federal level. The 
Strategy offers a way forward for such national leadership and action.
 
         
 
National Biosurveillance Strategy for Human Health V2.0     February 2010 
Appendix A: Lists of Contributors  61 
Appendix A: Lists of Contributors 
We have relied heavily on our workgroups to provide feedback on The Strategy. Many in the 
workgroups below including individuals from federal agencies, state and local public health 
departments, academic and professional organizations, and the private sector provided extensive 
comments on this Strategy and we are grateful for their contributions. Membership in the 
workgroups is subject to periodic change.  On-going involvement and comments from active 
participants will continue to guide The Strategy’s evolution. 
HSPD-21 Federal Biosurveillance Work Group  
Jonathan Ban, DHHS; Kristine Beardsley, DOI; Laurence Broun, DOI; James Callaghan, FDA; 
Steve Curran, HHS; J.C. Cantrell; CDC, Illka Chavez , CDC; Erica Canzler, EPA; Rick 
Cocrane, LMI; Stephen Curren, HHS; Judi Davenport, DOD; Karen Deasy, CDC; Scott Dowell, 
CDC; Lydia Duckworth, MITRE; Terrance Egland, NDU; Jessica Fontinato, USDA; John 
Fitzpatrick, CDC; Shawn Fultz, VA; Maria Giovanni, NIH; Alyce Girardi, DNI; Larry Granger, 
USDA; Walter Harris, CDC; Pamela Henderson, DHHS; Mark Holodniy, VA; Pam Holton, 
DOL; Bob Hooks, DHS; Susan Howe, DOL; Dawna Jones, DNI; Larry Kerr, DNI; Amy Kircher, 
DOD; Deborah Knott, USDA; Diane Kotra, OSD; Lara Lamprecht, DHHS; James Lawler, 
HSC; Helen Lawrence, FBI; Ronald Lawrence, WH; Karen Lee, FDA; Mike Lewis, DOD; Rob 
Lipnick, DOD; Jack Longmire, CDC; Cynthia Lucero, VA; Andrew McCabe, FDA; Carol 
Maczha, USDA; Carmen Maher, FDA; Donald Malinowski, DHHS; David Marcozzi, EOP; Afif 
Marouf, DHS; Carter Mecher, OS; Craig Miller, DHHS; Joy Miller, NCMI; Matt Minson, 
DHHS; Christy Music, DOD; Eric Myers, DHS; Nitan Natarajan, DHHS; Gina Oda, VA; 
Jennifer Olsen, DHHS; Cayce Parrish, EPA; Dina Passman, HHS; Mike Perry, NCPHI; Morris 
Potter, FDA; Eric Prentice, DNI; Teresa Quitugua, DHS; Reginald Richards, DOL; Barry 
Rhodes, CDC; Robert Scripp, FBI; Dean Seneca, CDC, David Siegrist, MITRE; Kimothy Smith, 
DHS; Rosemary Sokas, MOH; Jerome Tokars, CDC; Elaine Wolff, DOI; Sharon White, EPA; 
David Wong, HIS; Ted Yee, DOL; Stephen York, DHS. 
State, Local, Territorial and Tribal Work Group 
Henry Anderson, Wisconsin Division of Public Health; Paul Biedrzycki City of Milwaukee 
Health Department; Heather Brown, Maryland Department of Health and Mental Hygiene; 
Bryan Buss, Nebraska Department of Health and Human Services; David Butcher, Colorado 
Department of Public Health and Environment; Thomas Craig, CDC, Division of State and 
Local Readiness; James Collins, Michigan Department of Community Health; Dan Drociuk, 
South Carolina Department of Health and Environmental Control; Jeffrey Engel, North Carolina 
Department of Health and Human Services; Brian Fowler, Ohio Department of Health; Costanza 
Galastri, National Association of County and City Health Officials; Lynn Giljahn, Ohio 
Department of Health; Debra Gilliss, California Department of Public Health; Jack Herrmann, 
National Association of County and City Health Officials; Richard Hopkins, Florida Dept of 
Health; Jeff Johnson, County of San Diego Health and Human Services Agency; Lily Kan, 
National Association of County and City Health Officials; James Kirkwood, New York State 
Department of Health; Susan Lance, Georgia Division of Public Health; Anita McLees, CDC, 
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Division of State and Local Readiness; Michelle Meigs, Association of Public Health 
Laboratories; Karen Mumford, CDC, Division of State and Local Readiness; Marc Paladini, 
New York City Department of Health and Mental Hygiene; Mohini Persaud, Albuquerque Area 
Southwest Tribal Epidemiology Center; Marjorie Pollack, ProMED, International Society for 
Infectious Diseases; Thomas, Safranek, Nebraska Department of Health; Mary Shaffran, 
Association of Public Health Laboratories; Vanessa Short Bull, Northwest Portland Area Indian 
Health Board; Susan Smolinske, Children's Hospital of Michigan Regional Poison Control 
Center; John Trowbridge, University of California at San Francisco; Richard Vogt, Tri-County 
Health Department; Donald Ward, Maine Center for Disease Control and Prevention; Tim 
Wiedrich, North Dakota Department of Health Emergency Preparedness & Response; Brenda K. 
Wright, Animal and Plant Health Inspection Service.
CDC Biosurveillance Strategy Meeting and Biosurveillance 
Advisory Team 
Gerald Aben, Arthur Arias, Ray Arthur, Lynn Austin, Stephanie Bailey, Timothy Barrett, Beth 
Bell, Jay Bernhardt, Taknisha Johnson Bey, Lynn Blevins, Stephen Blount, Chris Braden, Peter 
Briss, Clive Brown, Blake Caldwell, Enzo Campagnolo, Kris Carter, Kenneth Castro, Marty 
Cetron, Thomas Chester, Rohit Chitale, David Clark, Catherine Chow, Mitchell Cohen, Janet 
Collins, Joanne Cono, June Cook, Maria Cooper, Toby Crafton, Carol Gotway Crawford, 
Miguel Cruz, Marsha Davenport, Robert Curlee, Catherine Dentinger, Debbie Deppe, Pamela 
Diaz, Phil Dillard, Scott Dowell, Tim Doyle, Richard Driscoll, Robin Eggleston, Henry Falk, 
Aaron Fleischauer, Renee Funk, Donna Garland, Genny Gallagher, Maleeka Glover, Brant 
Good, Samuel Groseclose, David Groves, John Halpin, Tamara Hamaty, Kerry Harrell, Walter 
Harris, Leslie Hausman, Thomas Hearn, Janet Heitgerd, Rita Helfand, Joy Herndon, Kimberly 
Hinton, Harvey Holmes, Yolonde Holt, John Horan, Taha Kass-Hout, Edward Hunter, Inzune 
Hwang, Robin Ikeda, Ruth Ann Jajosky, Daniel Jernigan, Shane Joiner, Gerald Jones, Kammy 
Johnson, Judy Kenny, Rima Khabbaz, Ali Khan, David Kim, Kathleen Knudsen, Valerie Kokor, 
Denise Koo, Lisa Koonin, Christine Kosmos, Jim Lando, Brian Lee, Lisa Lee, John Lipsky, 
Charles Magruder, Colleen Martin, Martin, Robert Dr. Tonya D Martin, Alison Mawle, Sandra 
McGill, Scott McNabb, Ninad Mishra, Melissa Morrison, Janice Nall, Philip Navin, Rebecca 
Noe, Rachel Kreh Nelson, Bill Nichols, Ann O'Connor, Jean O'Connor, Ralph O'Connor, Dennis 
O'Keefe, Daniel O'Leary, Stephanie Ostrowski, Ami Patel, Andrew Pelletier, Mike Perry, 
Stephen Pickard, Robert Pinner, Michelle Podgornik, Daniel Pollock, William Porter, Stephen 
Redd, Barry Rhodes, Margaret Riggs, Henry Rolka, Sandra Roush, Peter Rzeszotarski, Jaspal 
Sagoo, Louis Salinas, Michael Sapp, Donald Shriber, James Schwendinger, James Seligman, 
Katie Shebesh, Robert Sheppard, Alvin Shultz, Tom Sinks, Steve Solomon, Edward Sondik, 
Edward Sontag, Dan Sosin, Mike St. Louis, Joyce Millender-Steele, John Stinn, Rebecca 
Sunenshine, Nato Tarkhashvili, Pete Taylor, Richard Taylor, Stephen Thacker, Binny Thomas, 
Craig Thomas, Douglas Thoroughman, Jerome Tokars, James Tolson, Thomas Torok, Jeanne 
Tropper, Demetri Vacalis, David Walker, Marsha Vanderford, David Walker, Keith Williams, 
Amy Funk Wolkin, Mark Wooster, Tadesse Wuhib, Sara Zeigler. 
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National Biosurveillance Advisory Subcommittee (NBAS) 
NBAS Members
Tomas Aragon, UC Berkeley School of Public Health; Larry Brilliant, Skoll Urgent Threats 
Fund; Alvin Bronstein, Rocky Mountain Poison Center; Ron Brookmeyer, The Johns Hopkins 
Bloomberg School of Public Health; Ruth Carrico, University of Louisville; Heather Case, 
American Veterinary Medical Association; Sanford Climan, Entertainment Media 
Ventures;Denis Coulombier, European Centre for Disease Prevention and Control;Suzanne 
Frances Delbanco, Arrowsight, Inc; Jeffery Engel, North Carolina Department of Health and 
Human Services; James Hadler, Connecticut State Department of Public Health; Margaret 
Hamburg, Food and Drug Administration; David Heymann, Health Protection Agency;James 
Allen Heywood, PatientsLikeMe; Steven Hinrichs, University of Nebraska Medical 
Center;Gregory Istre, Injury Prevention Center of Greater Dallas; Paul Jarris, Association of 
State and Territorial Health Officials; Scott Layne, University of California Los Angeles School 
of Public Health; W. Ian Lipkin, Columbia University; Jonathan Lord, Humana Inc; Cecil Lynch, 
University of California at Davis; Kenneth Mandl, Children’s Hospital Boston; Linda McCauley, 
University of Pennsylvania School of Nursing; Farzad Mostashari, Office of the National 
Coordinator for Health IT; Tara O'Toole, Office of Science and Technology for Homeland 
Security; Erica Pan, San Francisco Department of Public Health; Gregory Poland, Mayo Clinic 
and Foundation; Arthur Reingold, University of California, Berkeley School of Public Health; 
Cris Ross, MinuteClinic; John Russell, K & L Gates; William Stephens, Tarrant County Public 
Health; Rajeev Venkayya, The Bill and Melinda Gates Foundation; Michael Williams, St. Louis 
County Department of Health. 
NBAS Consultants 
Henry Anderson, Wisconsin Division of Public Health; Michael Ascher, University of California 
School of Medicine and Epidemiology; Jarbas Barbarosa da Silva Jr., Pan American Health 
Organization; Art Davidson, Director, Public Health Department; Joseph, DeRisi, UCSF / 
HHMIPaul Epstein, Harvard Medical School; David Paul Fidler, Indiana School of Law; Louise 
Gresham, NTI Global Health and Security Initiative; Adi Gundlapalli, University of Utah, 
School of Medicine; Rajat Gupta, McKinsey & Company; Jim Hughes, Emory University; 
Patrick Kelley, National Academy of Sciences; Jeff Levi, Trust for America's Health; Tracey 
McNamara, Western University of Health Sciences College of Veterinary Medicine Western 
University of Health Sciences College of Veterinary Medicine; Melinda Moore, Rand 
Corporation; Stephen Morse, Columbia University; Eric Rasmussen, InSTEDD; Ben Reis, 
Harvard Medical School; David Relman, Stanford University School of Medicine; Beth
Seidenburg, Kleiner Perkins Caufield & Byers; Madeleine Thomson, Columbia University; Ken 
Warner, University of Michigan School of Public Health; James Wilson, Veratect Corporation. 
Biosurveillance Coordination Unit 
Christine Bradshaw ,CDC; Mark Byers ,Lockhead Martin; Sharon Campolucci, CDC; Laura 
Conn, CDC: Kijafa Dickinson, Lockhead Martin; Mark Hall, MPRI; Janet Kennedy, Lockhead 
Martin;  Sunanda McGarvey, Northrop Grumman; Randall Mitchell,MPRI;  John Daniel Morris, 
MPRI; Robert Propst, MPRI; Jennifer Ward, CDC; Curtis Weaver, CDC; Richard White, MPRI.
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Appendix B: Acronym Glossary 
A 
ACD Advisory Committee to the Director of CDC 
AHIC American Health Information Community
AMIA American Medical Informatics Association
APHL Association of Public Health Laboratories
ARRA American Recovery and Reinvestment Act of 2009 
ASPH Association of Schools of Public Health 
ASPR Assistant Secretary for Preparedness and Response 
ASTHO Association of State and Territorial Health Officials
B 
BGP Biosurveillance Governance Partners 
   February 2010 
BIWAC Biosurveillance Indications and Warning Analytic Community 
C 
CDC Centers for Disease Control and Prevention
CMS Centers for Medicare and Medicaid Services
COTPER Coordinating Office for Terrorism Preparedness and Emergency Response 
CSTE Council of State and Territorial Epidemiologists
D 
DHS Department of Homeland Security 

DOD Department of Defense
 
E 
EARS Early Aberration Reporting System
EHR Electronic Health Records 
EIP Emerging Infections Program 
ELR Electronic Laboratory Results 
EOP Executive Office of the President 
ESSENCE Electronic Surveillance System for Early Notification of Community-Based 
Epidemics 

EWIDS Early Warning Infectious Disease Surveillance
 
F 
FACA Federal Advisory Committee Act 

FSIS Federal Surveillance Inspection System 

FTE Full-time employee 

G 
GAO Government Accountability Office 

GEIS Global Emerging Infectious Surveillance and Response System 

GIS Geographic Information System 
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GOARN Global Outbreak Alert and Response Network 

GPHIN Global Public Health Intelligence Network 

H 
HHS Health and Human Services 

HIE Health Information Exchange 

HIMSS Healthcare Information and Management Systems Society 

HIT Health Information Technology 

HITSP Healthcare Information Technology Standards Panel 

HL7 Health Level Seven
 
HSPD-21 Homeland Security Presidential Directive -21
 
I 
IBGHH Interim Biosurveillance Governance for Human Health
 
ICD International Classification of Diseases 

ICLN Integrated Consortium of Laboratory Networks 

IHR International Health Regulations
 
IRN Integrated Response Network 

ISDS International Society for Disease Surveillance 

IT Information Technology 

J 
K 
L 
LIMS Laboratory Information Management Systems 

LIS Laboratory Information Systems
 
LOINC Logical Observations Identifiers, Names, Codes 

M 
MOA Memoranda of Agreement 

MOU Memoranda of Understanding 

N 
NACCHO National Association of County and City Health Officials 

NBAS National Biosurveillance Advisory Subcommittee 

NBIC National Biosurveillance Integration Center 

NBIS National Biosurveillance Integration System 

NBRHH National Biosurveillance Registry for Human Health 

NHIN Nationwide Health Information Network 

NIOC NBIS Interagency Oversight Council 

O 
OMB Office of Management and Budget 
ONC Office of the National Coordinator for Health Information Technology 
OPDIVS Operating Divisions 
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OSTP Office of Science and Technology Policy 
P 
PAHPA Pandemic and All Hazards Preparedness Act 
PFGE Pulsed Field Gel Electrophoresis 
PHIN MS Public Health Information Network Messaging System 
PHIS Public Health Information System 
PL Public Law
PHLIP Public Health Laboratory Interoperability Project 
ProMED Program for Monitoring Emerging Diseases 
Q 
R 
RECs Regional Emergency Coordinators 

RSPH Rollins School for Public Health
 
S 
SA Situation Awareness 

SLTT State, Local, Tribal and Territorial 

SME Subject Matter Expert 

SOP Standard Operating Procedure 

T 
U 
USDA United States Department of Agriculture 
V 
W 
WHO World Health Organization 
X 
Y 
Z 
